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Abstract
Microglia, resident myeloid cells of the CNS, execute an enormous variety of different functions
like tissue surveillance, nursing of synapses, phagocytosis of foreign material or debris, and ini-
tiation of appropriate immune responses upon CNS infection and damage (Hanisch and Ket-
tenmann, 2007; Kettenmann et al., 2011). The duration of an immune response is thereby self-
limiting as it resolves with a successful combat of the threat. A sustaining threat, however, can
lead to an over-activation of microglia which switches their initially beneficial effect to a rather
detrimental outcome. This disturbed microglia phenotype leads to a variety of neuropsychiatric
disorders or neurodegenerative diseases and aggravates the disease outcomes, mostly resulting
in neurotoxicity (Gold and Khoury, 2015; Hickman et al., 2008; von Bernhardi et al., 2015). Tar-
geting microglia is therefore a promising therapeutic approach to oppose those diseases (Chen
et al., 2014; Wes et al., 2016). Though, microglia functions are in most cases performed by a mere
subpopulation, a drug targeting the whole microglia population would thereby effect not only
the subsets causing the neurotoxicity but also the subsets which try to resolve the disease (Biber
et al., 2016; Marshall et al., 2014; Olah et al., 2012; Venkatesan et al., 2010). Thus, to develop
a useful drug, which specifically targets a harmful subpopulation of microglia, the microglial
organization principle needs to be unraveled beforehand.
This study focused on the functional heterogeneity of a microglial immune response by investi-
gating cytokine producing microglia subsets confronted with a variety of stimuli conditions in
different environmental contexts. I observed a highly specific adaptation of those subsets. The
degree of adaptation is thereby dependent on the investigated function, the used stimulus, the
stimulus intensity and the microglia density. Further analysis revealed that the subpopulations
are not performing one single function but multiple functions at once. Function specific subpop-
ulations are thereby composed of subpopulations which perform other functions as well. These
results demonstrate an almost infinite organization complexity ofmicroglia subsets, highlighting
the importance of further research to fully understand the nature of microglia.
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Microglia are brain-resident myeloid cells and execute an enormous variety of different func-
tions within the central nervous system (CNS) including surveillance of the tissue, nursing of
synapses, phagocytosis of debris, cells or foreign material, and initiation of appropriate immune
responses upon damage or infection. They are highly motile cells involved in proper brain de-
velopment but also implicated with a variety of neurodegenerative and inflammatory diseases
(Hanisch and Kettenmann, 2007; Kettenmann et al., 2011). Microglia vary by local densities and
functional properties which makes them a very heterogeneous population of cells with the po-
tential to perform their huge repertoire of functions simultaneously bymultitasking and division
of labor (Gertig and Hanisch, 2014; Hanisch and Kettenmann, 2007; Lawson et al., 1990).
1.2 Origin of microglia
Microglia are the prime innate immune cells of the CNS, comprising approximately 10% of its
total cell number (Aguzzi et al., 2013). They form a robust, long living and self-renewing pop-
ulation of immune cells (Kierdorf et al., 2013) with no contribution from bone-marrow derived
progenitors under physiological conditions (Ajami et al., 2007). In a healthy environment mi-
croglia turnover is rather rare, but if microglia are depleted from brain or spinal cord they are
able to repopulate completely within 14 days from a small population of surviving microglia or
nestin-expressing microglial progenitor cells (Bruttger et al., 2015; Elmore et al., 2014; Yao et al.,
2016).
Unlike neurons and other glial cells which derive from the neuroectoderm, microglia are
of mesodermal origin (Chan et al., 2007; Prinz and Mildner, 2011). They derive from ery-
thromyeloid precursor cells in the yolk sac which transform into yolk sac macrophages during
primitive hematopoiesis and subsequently migrate into the brain where they become microglia
cells (Ginhoux et al., 2010; Hoeffel et al., 2015; Kierdorf et al., 2013; Masuda and Prinz, 2016). As
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microglia start to colonize the murine brain already at embryonic day 8.5-9.5 they play a crucial
role in shaping the CNS during development (Ginhoux et al., 2010).
1.3 Role of microglia in development
During embryogenesis, microglia are already present in the brain when neurons are still in the
process of migration, proliferation and differentiation. During this time, approximately 50% of
the newborn neurons undergo programmed cell death and do not become mature (Schafer and
Stevens, 2015). This process involves microglia which are responsible for phagocytosing these
newly generated non-surviving cells, as it was shown by various studies conducted in mice, rats
and zebrafish (Ferrer et al., 1990; Peri and Nüsslein-Volhard, 2008; Sierra et al., 2010).
Additionally, microglia regulate the number of neural precursor cells in the developing cerebral
cortex by phagocytosing a proportion of viable cells with no signs of cell death, apoptosis or
nuclear breakdown (Cunningham et al., 2013). In contrast, some findings also indicate a neuro-
protective role of microglia necessary for the survival of specific types of neurons (Ueno et al.,
2013). An in vitro study was even able to demonstrate the involvement of microglia on neural
precursor cell differentiation (Aarum et al., 2003), which was later confirmed in vivo (Xavier
et al., 2015).
Microglia are crucial for the synaptic maturation as well. Microglial processes reach develop-
ing synapses and remove redundant ones in a process called “synaptic pruning”. A deficiency
in this function leads to a rather immature brain circuitry and is assumed to be involved in
neurodevelopmental and neuropsychiatric disorders (Hoshiko et al., 2012; Paolicelli et al., 2011;
Schafer et al., 2012; Squarzoni et al., 2014; Zhan et al., 2014). A similar function of microglia
called ”synaptic stripping” which persists beyond development removes synapses from injured
neurons (Kettenmann et al., 2013). Studies on mice suggest an additional role of microglia in
the modification and elimination of synaptic structures upon alterations in visual experience
and multiple learning tasks, indicating a contribution to learning and memory (Parkhurst et al.,
2013; Tremblay et al., 2010).
Other studies have shown that microglia support neurogenesis and oligodendrogenesis by
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secreting specific cytokine mixtures into the subventricular zone of developing rat brains
(Shigemoto-Mogami et al., 2014). However, apart from their role in the developing brain, mi-
croglia exhibit also important functions to maintain the CNS homeostasis through lifetime. The
support of neurogenesis, for instance, lasts even beyond embryogenesis since microglia are re-
quired for proper adult neurogenesis as well (Ziv et al., 2006).
1.4 Microglia functions
Under normal physiological conditions microglia have a ramified appearance that is character-
ized by extended, branched processes. Even though the somata are rather fixed, their processes
are highly motile. They extend and withdraw continually, allowing the microglia to scan the
whole brain parenchyma for signs of disturbance within hours (Davalos et al., 2005; Nimmer-
jahn et al., 2005). Simultaneously, they monitor synapse function of neurons and are involved in
their elimination and restoration (Wake et al., 2009).
It is assumed that once microglia recognize an injured cell, debris or even a dying cell, they
respond appropriately by repair, support or phagocytosis (Hanisch and Kettenmann, 2007; Nim-
merjahn et al., 2005; Streit, 2002). However, when microglia recognize tissue injury or infection,
they shift rapidly from their surveilling state to a rather activated phenotype (Davalos et al.,
2005). In this state, microglia have a more amoeboid appearance which allows them to migrate
actively to the side of injury or infection by following chemotactic gradients (Davalos et al., 2005;
Haynes et al., 2006; Honda et al., 2001; Koizumi et al., 2007; Liu et al., 2009). Once microglia
arrive at the site of disruption, they start to initiate a range of situation-specific activities like
phagocytosis, proliferation, antigen presentation or secretion of cytokines and chemokines in
order to recruit additional immune cells from the periphery (Buttini et al., 1996; Graeber et al.,
1988; Hanisch, 2002; Kettenmann et al., 2011; Streit, 2002; Streit et al., 1989). To be able to detect
all kinds of threats and to adapt a proper immune response, microglia express a vast range of
different receptors allowing this discrimination.
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1.5 Microglia signaling
In order to sense any threat in form of pathogen-associated molecular patterns (PAMPs) or dam-
age/danger associated molecular patterns (DAMPs), microglia express pattern-recognition recep-
tors (PRRs) (Saijo and Glass, 2011). These receptors are able to recognize lipids, lipoproteins,
proteins and nucleic acids derived from bacteria, viruses, parasites and fungi as well as intra- or
extracellular proteins released by injured cells. One form of these PRRs are Toll-like receptors
(TLRs), which are also present in microglia.
TLRs are transmembrane proteins that have leucine-rich repeats on their extracellular domains
to recognize PAMPs and Toll-interleukin 1 (IL-1) receptor (TIR) domains on their intracellular
domains to transduct downstream signaling (Kawai and Akira, 2010). There are 12 functional
TLRs in mouse (TLR1-TLR9; TLR11-TLR13) and 10 in humans (TLR1-TLR10) (Akira et al., 2006).
TLRs divide into two subgroups depending on their cellular localization and the patterns they
recognize. The first group resides on the cell surface and consists of TLR1, TLR2, TLR4, TLR5,
TLR6 and TLR11. Those TLRs recognize mainly microbial membrane components. The second
group comprising TLR3, TLR7, TLR8 and TLR9 are exclusively intracellular, expressed on endo-
somes, the endoplasmic reticulum, endolysosomes or lysosomes, where they recognize mainly
microbial nucleic acids. TLRs can signal through two routes, they use either the MyD88 (myeloid
differentiation primary response gene 88) dependent signalling pathway which is used by all
TLRs except for TLR3 or the TRIF (TIR-domain containing adaptor protein inducing Interferon-
β) dependent signaling pathway which is used by TLR4 and TLR3. TLR4 is thereby an exception,
since it is able to signal through both pathways (Takeda and Akira, 2004).
TLR4 recognizes bacterial lipopolysaccharide (LPS), a cell wall component of gram-negative bac-
teria such as escherichia coli (Hoshino et al., 1999; Poltorak et al., 1998). To do so, the recep-
tor forms a complex with MD2 (myeloid differentiation factor 2), which allows binding of LPS
(Schromm et al., 2001; Shimazu et al., 1999). A multidimer composed of two copies of the afore
mentioned LPS-receptor complex recruits the TIR domain-containing adaptor protein (TIRAP)
and MyD88 which initiates the signaling for early-phase activation of NF-κB (nuclear factor
κB)(Akira et al., 2006). A subsequent internalization of the receptor complex recruits TRAM
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(TRIF-related adaptor molecule) and TRIF and initiates late-phase activation of NF-κB and induc-
tion of type I interferons. Activation of NF-κB through the describedMyD88- and TRIF-dependent
pathways regulates inflammatory processes by the induction of inflammatory cytokines (see fig-
ure 1.1, p.7) (Kawai and Akira, 2010) .
TLR2 forms heterodimers with either TLR1 or TLR6 (Ozinsky et al., 2000). Upon binding of
triacyl-lipopeptides from Gram-negative bacteria and mycoplasma (TLR2-TLR1 heterodimer) or
of diacyl-lipopeptides from Gram-positive bacteria and mycoplasma (TLR2-TLR6 heterodimer),
both heterodimers signal through the MyD88-dependent pathway to induce the production of in-
flammatory cytokines (Jin et al., 2007; Kawai and Akira, 2010; Schwandner et al., 1999; Takeuchi
et al., 1999).
TLR3 recognizes mainly double stranded RNA (dsRNA) from viruses and virus infected cells
(Alexopoulou et al., 2001). It signals through the TRIF-dependent pathway to express type I in-
terferons and inflammatory cytokines (Akira et al., 2006).
TLR5 is known to recognize flagellin, a protein produced by flagellated bacteria. It forms a ho-
modimer and induces NF-κB-dependent production of cytokines by the recruitment of MyD88
(Hayashi et al., 2001).
TLR7 and TLR8 detect single stranded RNA (ssRNA) from viruses and recruit MyD88 for the in-
duction of cytokine secretion and interferon regulatory factor 7 (IRF7) for the induction of type
I interferons (Heil et al., 2004; Hemmi et al., 2002).
TLR9 signals the same way as TLR7 and TLR8 but detects unmethylated cytidine-phosphate
guanosine (CpG) DNA from bacteria and viruses (Hemmi et al., 2000).
This repertoire of different receptors is necessary to induce situation specific immune responses
by microglia. However, a whole range of other receptor proteins besides TLRs are expressed in
microglia, but not all receptors are expressed in each cell which leads ultimately to the formation
of subpopulations carrying different receptor combinations. This heterogeneity of microglia is
not restricted to the expression of receptors, in fact, microglia heterogeneity can be found in
nearly each area of investigation.
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Figure 1.1 – Toll-like receptor signaling: TLR4 binds LPS by forming a complex with MD2. A multidimer
composed of two copies of this LPS-receptor complex recruits the TIR domain-containing adaptors TIRAP
and MyD88 which initiates the signaling for activation of NF-κB. A subsequent internalization of the recep-
tor complex recruits TRAM and TRIF and initiates once more activation of NF-κB which leads to the induc-
tion of inflammatory cytokines. Additional activation of IRF3 induces inductions of type I interferon. TLR2
forms heterodimers with either TLR1 or TLR6. Both heterodimers signal through the MyD88-dependent
pathway to induce the production of inflammatory cytokines upon binding of triacyl lipopeptides or diacyl
lipopeptides. TLR3 recognizes mainly dsRNA. It signals through the TRIF dependent pathway to recruit
type I interferons and inflammatory cytokines. TLR5 forms a homodimer after recognition of flagellin. It
induces NF-κB dependent production of cytokines by the recruitment of MyD88. TLR7 and TLR8 detect
ssRNA whilst TRL9 detects CpG DNA. They recruit MyD88 and IRF7 to induce cytokine secretion and pro-
duction of type I interferons, respectively.
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1.6 Microglia heterogeneity
Microglia contribute simultaneously to proliferation, maturation, survival and cell death within
the CNS. To perform these various activities, it is likely that microglia fall into subpopulations
depending on brain region and/or function.
1.6.1 Regional heterogeneity
Even though microglia are present in the whole CNS they are not uniformly distributed (Lawson
et al., 1990). As a result, microglia densities vary highly within the individual brain regions.
It was already shown in 1990 that mouse microglia compose approximately 5 % of all cells
in the cerebral cortex and corpus callosum. In the whole brain, this proportion rises region-
dependently up to 12 % as seen in the substantia nigra (Lawson et al., 1990). This region-
dependent microglia density was also demonstrated in the healthy human brain parenchyma
where the proportion of microglia ranged from 0.5 % up to 16 % (Mittelbronn et al., 2001). Re-
cent data show that there is not only regional heterogeneity in microglia density but also in their
gene expression profile (Grabert et al., 2016). Genome-wide analysis of microglia from cerebel-
lum, hippocampus, cortex, and striatum ofmice indicate thatmicroglia from the first two regions
have a more immune-alerted state than the latter two, and that they show a greater expression
of genes involved in energy metabolism (Grabert et al., 2016).
It was also shown, that neurons of different brain regions show diverse susceptibility to LPS-
induced neurotoxicity which is most probably related to the different abundance of microglia
in those regions (Kim et al., 2000). Other studies which investigated the expression of various
microglial immunoregulatory markers indicated that the expression level of each marker was
highly heterogeneous even though all of them were expressed within the tested brain regions
(de Haas et al., 2008; Ren et al., 1999; Smith et al., 2013). Investigation of several microglial
purinergic P2X receptors revealed not only a brain-region specific heterogeneity of their expres-
sion levels, but also an age- and even a sex-specific dependency (Crain and Watters, 2015). The
high complexity of regional microglia heterogeneity was even more validated by a study con-
ducted in the olfactory bulb of rats which could demonstrate that microglia expression levels of
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various markers differed even between the different layers of the tissue, highlighting the impact
of the microenvironment (Schmid et al., 2009; Wu et al., 1997).
1.6.2 Functional heterogeneity
Even though it was already shown in the 1990s that only subpopulations of microglia express im-
munologically important molecules like Major histocompatibility complex (MHC) class II (Streit
and Graeber, 1993) or specific neurotrophins (Elkabes et al., 1996), it was long believed that all
microglia behave or react rather homogeneously. The functional heterogeneity became more
and more evident within the recent years and draws increasing attention.
As such, it is nowadays known that the most essential microglial functions are performed by
mere subsets of microglia rather than the entire population at once. The phagocytosis of myelin
is only one example of these functions, performed by a subpopulation of microglia and plastic
in regards to the size of their population (Venkatesan et al., 2010). Microglia can also be classi-
fied into proliferative and non-proliferative populations with differing sizes, dependent on the
respective brain region and on the surrounding cellular environment (Marshall et al., 2014).
The expression patterns of receptors were found to be organized in a subpopulational man-
ner as well since only a fraction of microglia in rodents express GABAB-, glutamate-, dopamine-
or noradrenaline-receptors (Färber et al., 2005; Kuhn et al., 2004; Noda et al., 2000). Interest-
ingly, the fraction of cells that express these receptors varies with microglial activity. In ac-
cordance, the highly important immunological factor TREM2 (triggering receptor expressed on
myeloid cells 2) is only expressed in subpopulations of resting microglia and its expression is
brain-region- and most likely microenvironment-dependent (Schmid et al., 2002).
Microglia sensitivity towards neurotransmitters and neurohormones like histamine, seroto-
nine, somatostatin, angiotension II or dopamine is conveyed via subpopulations as well. The
neurotransmitter/neurohormone-dependent subpopulations can represent up to 20% of all mi-
croglia, and while some of the subpopulations are just able to react to one substance, some can
even react to two or three substances after sequential exposure (Pannell et al., 2014b).
An advancing knowledge on microglia subpopulations may also increase our understanding of
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a variety of central nervous diseases. In a mouse model of Alzheimer’s disease, for instance, ap-
plication of IL-4 (interleukin 4) leads to the expression of CD11c in a subpopulation of microglia
that specifically counteracts the inhibitory effects of beta-amyloid on microglia leading to im-
proved plaque phagocytosis and increased neurogenesis (Butovsky et al., 2006). In an ischemic
stroke mouse model, researchers identified distinct subpopulations of microglia producing TNFα
(Tumor necrosis factor α) or IL-1β (interleukin 1β) respectively after stroke induction (Clausen
et al., 2008). Keratan sulfate, an inhibitor of axonal regeneration, was also demonstrated to be
expressed by a microglia subpopulation in a mouse model of Wallerian degeneration (Shinjo
et al., 2014). In Hoxb8 mutant mice, the transgene is expressed by a subpopulation of about 40 %
ofmicroglia and a loss of functionmutation in this gene leads to excessive grooming and sensory
defects. This phenotype is similar to the obsessive-compulsive disorder which was observed in
humans (Chen et al., 2010). Taken together, studies regarding microglia subsets strongly suggest
a vast impact of microglia heterogeneity on the CNS immune system but also subsequent func-
tions of the CNS (Baalman et al., 2015; Bisht et al., 2016; Fang et al., 2014; Kobayashi et al., 2013;
Kocur et al., 2015; Pannell et al., 2014a; Pepe et al., 2014; Trias et al., 2013; Wlodarczyk et al.,
2015).
Apparently, the findings on functional heterogeneity in microglia are not limited to rodents, as
the complexity of microglial organization was successfully demonstrated in a study using mi-
croglia cultures from different human donors as well, since the culture cells showed similar
gene profiles but very diverse responses to a challenge. The differences elicited by the same
challenge even resulted in opposed gene expression changes between the cultures (Meeuwsen
et al., 2005).
The heterogeneity of microglia is not only restricted to areas, functionalities or expression pat-
terns, but also dependents on age. Studies conducted in young vs. old mice showed an altered
pro-inflammatory profile that comes with age (Godbout et al., 2005; Ritzel et al., 2015; Sierra
et al., 2007). These age-dependent alterations, which include microglial functions, self-renewal
and vitality are collectively termed as ”microglial senescense” (Streit, 2006). Interestingly, this
phenomenon as well as other microglia features are linked to a variety of neurodegenerative
diseases in which microglia seem to play an essential role (Block and Hong, 2005; Hickman et al.,
2008; Prokop et al., 2013).
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1.7 Microglia and diseases
Microglia are constantly screening the brain parenchyma for threats and disturbances (Nimmer-
jahn et al., 2005). Once they encounter a disruption of homeostasis, i.e. due to a pathology, they
try to resolve it (Davalos et al., 2005). Though, microglia stay activated as long as the pathology
sustains this could switch beneficial to detrimental outcomes or vice versa. In Alzheimer’s dis-
ease for instance, microglia are able to clear the toxic amyloid beta that accumulates in affected
brains. However, if they are confronted with amyloid beta continuously, they lose the ability to
clear it. This results in microglial activation, a massive release of pro-inflammatory cytokines
and production of reactive oxygen species, that ultimately lead to neurotoxicity and neurode-
generation (Gold and Khoury, 2015; Hickman et al., 2008). This over-activation of microglia was
also demonstrated in other neurodegenerative diseases like multiple sclerosis, frontotemporal
lobe dementia, Parkinson’s disease, hypoxia, stroke and amyotrophic lateral sclerosis (reviewed
in Block and Hong, 2005).
Even though the total impact of microglial activation on those diseases is still under investiga-
tion, it is already clear that targeting microglia to oppose the diseases is very promising (Chen
et al., 2014; Wes et al., 2016). Nonetheless, using anti-inflammatory drugs has a lot of side-effects
since they are targeting the whole system, outmaneuvering even the beneficial functions (Biber
et al., 2016; Olah et al., 2012). Thus, understanding microglia as a heterogeneous population of
immune cells and identification of respective markers to differentiate between the subgroups
would be crucial to counteract the strong inflammatory response in those diseases. The devel-
opment of drugs or tools that are specifically targeting subpopulations of interest while leaving
the others unaffected would be of most benefit (Ferreira and Bernardino, 2015).
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1.8 Aim of the thesis
Even though the consciousness of microglial heterogeneity is advancing, research specifically
investigating microglial subpopulations is still in it´s infancy. So far, most studies that identified
microglial subgroups were primarily interested to address completely different issues. Thus, the
existence of microglial subpopulations is known andmostly accepted, their organization and be-
havior, however, is completely unknown. Thus, this study aimed to investigate the organization
of specific subpopulations and their behavior in different conditions. By focusing on two main
functions of microglia, namely cytokine secretion and proliferation, I addressed the following
research questions:
1. How do microglia subpopulations behave in front of a challenge? Is an increased cytokine
release caused by an increased cell number or by a higher cytokine production per cell?
2. Can microglia subpopulations secrete multiple cytokines? How are the cytokine-specific
subgroups organized?
3. Occurs secretion and proliferation simultaneously in the same microglia cell?




C57Bl/6J wildtype mice were bred and housed under normal conditions in the Central Animal
Facility of the University Medical Center Göttingen (UMG). Mutant strains (myd88−/− and triflps2,
both on C57Bl/6J background) were bred and maintained under specific pathogen-free condi-
tions in the same facility. The myd88−/− mice were kindly provided by Prof. Dr. Marco Prinz
(Department of Neuropathology, University of Freiburg, Germany) and described by Adachi and
colleagues (Adachi et al., 1998). The triflps2 mice were provided by Dr. Bruce Beutler (Univer-
sity of Texas Southwestern Medical Center, USA), carrying a mutation in the C terminus of TRIF
which abolishes TRIF-mediated functions (Hoebe et al., 2003). All animals were supplied with
food and water ad libitum. Experiments were performed in accordance with the guidelines for
animal welfare and protection of the University Göttingen and the German Animal Protection
Law.
2.2 Primary Mouse Microglia Preparation
Primary cultures were prepared from whole brains of newborn (P0/P1) wildtype C57Bl/6J, or
myd88−/− and triflps2 mutant mice as described by Regen et al. 2011. Mice were decapitated, the
brains were extracted and immediately transferred into petri-dishes containing ice-cold Hanks
balanced salt solution (HBSS) (Biochrom; #L2012). Following the removal of blood vessels and
meninges from the brains with help of a binocular stereo microscope, brain tissue was collected
in a Falcon tube containing ice-cold HBSS. After being washed trice, the brains were digested
with 100 µl 2.5% Trypsin/brain (Biochrom; #L2133). The tubes were gently vortexed and incu-
bated for 10 minutes in a 37◦C water bath with additional vortexing in between. The digestion
was stopped by addition of 1 ml/brain medium (Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco; #41965-062)) containing 10% fetal calf serum (FCS) (Invitrogen), 100 U/ml penicillin, and
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100 µg/ml streptomycin (Biochrom; #A2213). Next, 40 µl/brain deoxyribonuclease (DNase) (Wor-
thington; #2139) was added to avoid excessive DNA aggregation. Brain structures were dissolved
carefully by pipetting up and down several times. A subsequent incubation for 3 minutes at 37◦C
in a water bath ensured a complete decomposition of the tissue. Afterwards, samples were cen-
trifuged at 900 rpm (163 g) for 10 minutes at 4◦C. For culturing, the cells were resuspended in 15
ml medium/2 brains in a F75 cell culture flask (Greiner; #658175). Flasks were pre-coated with
Poly-L-Lysin (PLL) (Sigma Aldrich; #P1274). To pre-coat the flasks with PLL, they were incubated
for 20 minutes with 10 ml PLL and washed thrice with sterile ddH2O and once with medium.
Flasks containing cells were incubated overnight at 37◦C with 5% CO2.
The next day, cells were washed trice with phosphate buffered saline (PBS) (Gibco; #14190-094)
and once with medium. Cells were washed again with medium on day 3 and 4. On day 9, cells
were shaken for 20 minutes at 37◦C at 90 1/min and themediumwas substituted with 10ml fresh
medium and 5 ml conditioned L-929 medium. The first microglia could be harvested on day 14.
Therefore, flasks were shaken for at least 30 min at 37◦C at 900 rpm (163 g) and the microglia
containing supernatant was transferred into a falcon tube. The remaining cells in the flask were
supplied with 10 ml medium and 5 ml L-929 medium and incubated at 37◦C with 5% CO2 till
the next harvest. The tube containing the microglia was centrifuged at 4 ◦C and 900 rpm (163
g) for 10 min. The supernatant was discarded and cells were resuspended in a small amount of
medium. Afterwards, cells were counted (cellomoterTM Auto T4; Nexcelom Bioscience), resus-
pended and plated (cell-culture plates CellstartR, Greiner bio-one) at the desired densities needed
for the individual experiments. Additional harvests were performed on day 16, 21 and 23.
The purity of microglia preparations was routinely >98%, based on nuclear staining (DAPI), im-
munocytochemistry for CD11b, Iba1 and Griffonia simplicifolia isolectin B4 (Regen et al., 2011;
Scheffel et al., 2012).
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2.3 L929 fibroblast cultures
To stimulate microglial proliferation in culture, cells were provided with supernatant from L929
fibroblasts as described by Regen et al. 2011. Fibroblasts were cultured in medium (DMEM
containing 10% FCS; 100 U/ml penicillin and 100 µg/ml streptomycin) and passaged (1:5) every
2 weeks. After 14 days of cultivation, the medium was collected and centrifuged at 1200 rpm
(290 g) for 10 min at 4◦C. Finally, the cell pellet was discarded and the supernatant was stored
at -20◦C until usage. Fibroblasts were discarded after 30 passages and fresh L929 cultures were
established.
2.4 Cytokine and chemokine measurements
The amount of secreted cytokines and chemokines by microglia was measured by using enzyme-
linked immunosorbent assay (ELISA). For ELISA, the DuoSet ELISA Development Kits (R&D sys-
tems) were used for IL6 (interleukin 6) (#DY406), MCP-1 (monocyte chemotactic protein 1) (
#DY471), MIP1α (macrophage inflammatory protein 1α) (#DY450), RANTES (regulated upon acti-
vation normal T-cell expressed and presumably secreted) (#DY478) and KC (keratinocyte-derived
chemokine) (#DY453). For TNFα and for IL12-p40 (Interleukin 12), antibody pairs from BioLe-
gend (#430902) and eBioscience (#88-7120-88) were used respectively.
In brief, microglia were plated in a 96-well plate with a density of 15000 cells/well. After incuba-
tion overnight at 37◦Cwith 5% CO2, cells were stimulated for 18 hours (if not stated differently) at
37◦C with 5% CO2. Subsequently, supernatants were transferred into new 96-well plates (Sarst-
edt; #82.1581) and stored at 4◦C or -20◦C for immediate or later processing, respectively. ELISA
plates (Maxisorp; Nunc; #456537) were coated with 50 µl/well of the specific capture antibody so-
lutions and incubated overnight at room temperature (RT) with a gentle agitation. Then, plates
were washed 3 or 4 times (antibody dependent) with wash buffer (0.5% Tween 20 in PBS) and
blocked with 300 µl/well of reagent diluent 1 (RD1) (1% BSA in PBS) for 1 hr at RT or overnight at
4◦C. Supernatants were diluted 1:10 (IL6; MCP-1; IL12-p40; RANTES; TNFα) or 1:20 (KC; MIP1α) in
RD1 in dilution plates (Sarstedt; #82.1582) and series of standard solutions provided by the kits
were prepared. After discarding the block solution, plates were washed as mentioned above and
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50 µl/well of the diluted supernatants as well as the standards were added and incubated for 2
hours at RT or overnight at 4◦C. Next, plates were washed and 50 µl/well of the detection anti-
body solution was added for 2h at RT. After washing, wells received 50 µl of a Streptavidin-HRP
solution (R&D; #893975) for 20 minutes at RT protected from light. Following the next washing,
100 µl substrate solution (TMB; Moss Inc. #TMBUS-1000) was added and the color development
was stopped by addition of 50 µl/well of 1NH2SO4. Absorbancewasmeasured at 450 nmwith 540
nm reference by an iMark microplate reader (Bio-Rad). The amount of secreted cytokines and
chemokines was calculated using a Microsoft Excel macro, specifically developed for this pur-
pose by Dr. Jörg Scheffel and optimized at the department of neuropathology at the University
Medical Center Göttingen.
2.5 Cell viability assessment
To determine any possible toxicity of the stimuli used for ELISA experiments on microglia, the
cell viability test was performed routinely. To do so, microglia received fresh medium supple-
mented with 10 % of water soluble tetrazolium salts (WST-1) reagent (Roche Applied Science)
immediately after the transfer of the supernatant. The absorbance was quantified as a measure
for viability after 3 hours of incubation at 37◦C with 5% CO2 using a microplate reader (iMark;
BioRad) at 450 nm with 655 nm as the reference wavelength.
2.6 Bromodeoxyuridine (BrdU) Cell Proliferation ELISA
To assess microglia proliferation, the BrdU Cell Proliferation ELISA kit (Roche; #11647229001)
was used. Microglia were plated in a 96 well-plate with a density of 15000 cells/well and in-
cubated for 24 hours at 37◦C with 5% CO2. Subsequently, the medium was replaced by vari-
ous stimuli solutions including LPS (#ALX-581-007, Alexis Biochemicals), Pam3CSK4 (#165-066-
M002; Alexis Biochemicals) and Fibronectin (FN) (#F-1141; Sigma) of different concentrations
(0.01 ng/ml; 1 ng/ml; 100 ng/ml for LPS and Pam3CSK4, 25µg/ml; 50 µg/ml; 100 µg/ml for FN)
mixed with 10 µM BrdU. Medium containing 10 µM BrdU was used as control. Incubation for
6, 12, 24 or 48 hours followed by further processing as described by the BrdU Cell Proliferation
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ELISA assay. In brief, supernatants were removed and cells were fixed with 200 µl/well FixDenat
(provided by the assay) for 30 minutes at RT on a shaker. Next, supernatants were discarded
and cells were incubated with 100 µl/well anti-BrdU-POD working solution for 90 minutes at RT
on a shaker. Cells were washed thrice with 200 µl/well PBS and incubated with 100 µl/well sub-
strate solution for 5 minutes at RT. The reaction was stopped by addition of 25 µl 2N H2SO4 for
1minute on a shaker. Absorbance was measured by an iMark microplate reader (Bio-Rad) at 450
nm (reference wavelength 690 nm or higher).
2.7 Enzyme Linked Immuno Spot Assay (ELISpot)
Production of TNFα and RANTES by individual microglia was quantified via Elispot.
For TNFα ELISpot experiments, the ELISpot assay against mouse TNFα (# EL410; R&D) or the
TNFα/TNFSF1A ELISpot Development Module (R&D; #SEL410) were used. RANTES experiments
were performed with the Mouse CCL5/RANTES ELISpot Development Module (R&D; #SEL478).
Both development modules were combined with the ELISpot Blue Color Module (Strep-AP and
BCIP-NBT) (R&D #SEL002) on Multiscreen HTS IP sterile plates (Millipore #MSIPS4510).
The ELISpot plates were prepared as described by the manufacturer’s instructions and a cell
suspension mixed with different concentrations of LPS (Alexis Biochemicals; #ALX-581-013),
Pam3CSK4 (Alexis Biochemicals; #165-066-M002) or MALP-2 (Macrophage-activating lipopeptide-
2) (Axxora/Apotech; #APO-54N-018) was platedwith a cell density of 1000, 2000 or 3000 cells/well.
ELISpot plates were incubated at 37◦C with 5% CO2 for 24 hours and the development process
was assessed according to the manufacturer’s instructions. Spots were counted by the ELISpot
reader ELI.Scan and analyzed using Eli.Analyse (both A.EL.VIS GmbH; Hannover). The obtained
spot number was used for calculating the sizes of the subpopulations. The readouts for Spot in-
tensities as well as the spot sizes were ranked in values between 1 to 17 and 1 to 10, respectively.
As controls, cells with the same density and stimulation conditions as used for the Elispot plate
were plated on a separated plate (CellstartR, Greiner bio-one) simultaneously. This control plate
was used for ELISA analysis of the cytokine secretion and viability tests.
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2.8 Fluorescence-activated cell sorting (FACS)
FACS was performed to quantify microglial subpopulations. For intracellular FACS staining of
microglia, cells were plated at a density of 300000 cells/well in a 12-well plate unless otherwise
stated. After an overnight incubation at 37◦C with 5% CO2 cells were stimulated with 0.01 ng/ml;
0.1 ng/ml; 1 ng/ml; 10 ng/ml; 100 ng/ml or 1000 ng/ml LPS (Alexis Biochemicals; #ALX-581-013)
for 8 hours.
The protein transport inhibitor Monensin (BioLegend, #420701; 1:1000) was added after a stimu-
lation period of 3 hr (for RANTES staining or a RANTES/TNFα double staining) or 5 hr (for TNFα
staining) respectively. The stimulation was stopped by washing steps with medium and PBS.
Cells were detached via incubation with 300 µl 0.05 %/0.02 % Trypsin/EDTA (Biochrom; #L2143)
for 5 minutes at 37◦C. This reaction was stopped by adding 600 µl medium. Cells were scraped
carefully and transfered to 2 ml Eppendorf tubes placed on ice. Subsequently, tubes were cen-
trifugated at 800 g for 10 min at 4◦C and the supernatant was discarded. Cells were resuspended
in 1ml FACS buffer (PBS containing 2% FCS, 0.1% NaN3 and 0.01 M EDTA pH 8.0) and centrifuged
again. Supernatants were discarded and cells were incubated with 40 µl Fc-Block (BioLegend;
#101310;1:100 in FACS buffer) for 10 min at 4◦C to prevent unspecific antibody binding. 40 µl
CD11b-Allophycocyanin (Cd11b-APC) (eBioscience; #17-0112-83) or CD11b-Pacific Blue (CD11b-
PB) (BioLegend; #101224) both diluted 1:100 in FACS buffer were added to the respective wells
and incubated for 20 min at 4◦C protected from light. Afterwards, cells were washed with 1
ml FACS buffer and centrifuged at 800 g for 10 min at 4◦C. A resuspension of the cells in 200 µl
Cytofix/ Cytoperm (BD; #51-2090KZ) was performed after discarding the supernatants. Cells were
incubated for 20 min at 4◦C protected from light, washed with 1ml saponin buffer (0.1% Saponin
(Sigma Aldrich; #S-4521) in PBS) and centrifuged at 800 g for 10min at 4◦C. Supernatants were re-
moved and cells were incubated with 40 µl Fc-Block (1:100 in saponin buffer) for 5 min followed
by addition of RANTES-Phycoerythrin (RANTES-PE) (BioLegend; #149104), TNFα-PE (BioLegend;
#506305) or TNFα-Alexa Fluor 488 (BioLegend; #506315), all 40 μl, 1:100 in saponin buffer for 40
min at RT protected from light. Cells were washed with saponin buffer and centrifuged for at
800 g for 10 min at RT. Finally, cells were re-suspended in 170-200 µl FACS buffer and analyzed
via the FACS Canto II (BD) and Flowjo (Tree Star, V10) software. For FACS analysis only Cd11b
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positive events were included.
For Zombie Aqua staining, cells were treated as mentioned above until the first wash step which
was performed with PBS instead of FACS buffer. Cells were incubated with Zombie aqua (1:200
in PBS) for 10 min at RT protected from light followed by addition of the Fc-Block (1:100) and the
CD11b (1:100) antibody.
To stain the proliferating cells, the Click-iT R© EdU (5-ethynyl-2’-deoxyuridine) Alexa Fluor R© 647
Flow Cytometry Assay Kit (ThermoFischer SCIENTIFIC #c-10419) was used. Cells were stimulated
with 1 ng/ml LPS (Alexis Biochemicals; #ALX-581-013) in combination with 5 µM EdU (provided
by the Kit) and harvested as mentioned before. Afterwards, cells were washed in 1 ml of 1%
BSA in PBS and incubated with Fc-Block and CD11b-PB prepared in 1% BSA in PBS as well. Fix-
ation, permeabilization, and EdU staining were performed as described by the proliferation kit.
Intracellular antibodies were stained afterwards in Click-iT saponin based permeabilization and
wash reagent instead of FACS buffer.
2.9 Supernatant transfer experiment
For the supernatant transfer experiment 200000 or 5000000 microglia cells were plated in a 12-
well plate and incubated over night at 37◦C with 5 % CO2. The next day, wells received either
fresh medium or LPS (1 or 10 ng/ml) for 8 hours. Afterwards supernatants were transferred
to wells containing 200000 unstimulated microglia. Microglia which received supernatant from
LPS stimulated cells were left untouched for 8 hours. Microglia which received supernatant
from unstimulated cells were stimulated with 1 or 10 ng/ml LPS for 8 hours.
This paradigm generated 3 different treatment groups. The first, the control group, consisted
of 200000 unstimulated cells and 200000 cells that received the supernatant of 500000 unstim-
ulated cells for 8 hours. The second group consisted of 200000 LPS-stimulated (1ng/ml) cells or
200000 cells with the supernatant of 500000 unstimulated cells that were stimulated after the
supernatant transfer with 1 ng/ml LPS for 8 hours. The third groupwas made up by 200000 cells,
treated for 8 hours with supernatants of 200000 or 500000 cells that were already stimulated
with 1 ng/ml LPS for 8 hours beforehand.
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During the last incubation step microglia were supplemented with monensin for a subsepquent








Figure 2.1 – Schematic plating overview of the insert
experiment with microglia indicated as green lines,
and supernatant concentrations indicated in red.
To evaluate the effect of the supernatant
secreted by increasing numbers of mi-
croglia on microglia subpopulation sizes,
an insert experiment was performed.
Therefore, microglia were plated at a den-
sity of 200000 cells in a 12-well plate.
Some of these wells received transmem-
brane cell-culture inserts (greiner bio-one
#665640) containing addditional 100000,
200000 or 300000 microglia. After an overnight incubation at 37◦C with 5 % CO2, microglia
were stimulated with 1 ng/ml LPS for 8 hours. After the first three hours monensin was added
to prevent cytokine secretion and after additional 5 hours microglia were further processed for
FACS analysis of TNFα.
2.11 Ribonucleic acid (RNA) extraction
To extract RNA the RNeasy Mini Kit (Qiagen; # 74104) was used. 800000 microglia/well were
plated in a 6-well plate and stored at 37◦C with 5% CO2. Next, microglia were incubated with
10 ng/ml TNFα for 1 or 12 hours at 37◦C with 5% CO2. Supernatants were discarded, cells were
washed and incubated with 1 ng/ml LPS for 3 hours at 37◦C with 5% CO2. Afterwards, cells
were washed with pre-warmed PBS and received 350 µl RLT buffer (if not stated otherwise pro-
vided by the kit) containing 1% β-Mercaptoethanol. Cells were scraped carefully, the lysates were
transferred into Eppendorf-tubes and after resuspension into QIAshredder Mini Spin Columns
(Qiagen; #1011711). The columns were centrifuged at maximum speed for 2 minutes and 350 µl
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70% EtOHwas added to the lysate containing collection tubes. Lysates were transferred after re-
suspension to RNeasy Mini Spin Columns (Qiagen; #1011708) and centrifuged for 30 sec at 8000
g. Collection tubes were emptied, 350 µl RW1 buffer was added on top of the spin columns and a
centrifugation at 8000 g for 30 sec followed. Then, 75 µl DNase mix (8,75 µl DNase + 61,25 µl RDD
buffer) was added on top of the spin column membranes and incubated for 15 minutes at RT.
Subsequently, 250 µl RW1 buffer was added and the column was centrifuged for 30 sec at 8000
g. Collection tubes were emptied, 500 µl RPE buffer was added and the column was centrifuges
as before. Next, RPE buffer was added again and centrifuged for 3 min at 8000 g. The collec-
tion tube was replaced by a new one and the columns were centrifuged for 1 min at maximum
speed. Finally, columns were placed in Eppendorf tubes, 25 µl nuclease-free water was added
and centrifuged for 1 min at 8000 g. This step was repeated onemore time and the obtained RNA
concentrationwasmeasured using the NanoDropND-1000 Spectrophotometer (PEQLAB) and the
corresponding software version 3.8.1. Samples were stored at -80◦C until further processing.
2.12 Complementary deoxyribonucleic acid (cDNA) synthesis
For quantifying changes in gene expression upon stimulation, quantitative Real-Time Poly-
merase chain reaction (RT-PCR) was performed. cDNA for RT-PCR was synthesized by using
the QuantiTect Reverse Transcription Kit (Qiagen; #205311) as followed: the template RNA was
thawed on ice and the genomic DNA (Deoxyribonucleic acid) elimination cocktail was prepared.
The composition was RNA concentration dependent and contained 300 ng RNA, 2 µl wipeout
buffer and RNase- free water to make a total volume of 15 µl. This mixture was incubated for 2
minutes at 42◦C and immediately placed on ice afterwards. Next, the reverse transcription mas-
ter mix containing 1 µl Quantiscript Reverse Transcriptase, 4 µl Quantiscript RT buffer (5x) and
1 µl RT Primer mix per sample was prepared. 14 µl of the DNA elimination cocktail was mixed
with the reverse transcription master mix and incubation at 42◦C for 15 minutes and 95◦C for
3 minutes followed. Finally, 100 µl RNase-free water was added to each sample (1:6 dilution)
and samples were transferred to a 96-well plate and stored at -20◦C until further processing by
real-time PCR.
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2.13 RT-PCR
For RT-PCR iTaq universal SYBR Green supermix (BIO-RAD; #172-5121) and cDNA was thawed
at RT. For each desired sample, 10 µl iTaq universal SYBR Green supermix, 1 µl forward and
reverse primer (see table 2.1) and 4 µl H2O was mixed. 15 µl of this mixture was added in
triplicates to a qPCR plate and 5 µl of the appropriate cDNA was added to the mixture. The plate
was sealed with an optically transparent sealing tape (Sarstedt; #95.1994) and vortexed for 30 s.
Next, the plate was centrifuged at maximum speed for 5 minutes to remove air bubbles within
the wells. The plate was inserted into the real-time cycler QuantStudio 7 Flex (life technologies)
and processed as described (see table 2.2). Results were analyzed using the QuantStudio Real-
time PCR Software (version 1.1; life technologies). Relative mRNA expression for MCP-1, MIP1α,
RANTES, KC and TNFα was calculated by 2−∆∆CT to medium controls with Gapdh as the control
gene.
Table 2.1 – RT-PCR primer
Name Company Number
PrimePCRTM SYBR R© Green Assay: TNF, Mouse BIO-RAD qMmuCED0004141
PrimePCRTM SYBR R© Green Assay: MIP1α, CCL3, Mouse BIO-RAD qMmuCED0003870
PrimePCRTM SYBR R© Green Assay: RANTES, CCL5, Mouse BIO-RAD qMmuCID0021047
PrimePCRTM SYBR R© Green Assay: Gapdh, Mouse BIO-RAD qMmuCED0027497
PrimePCRTM SYBR R© Green Assay: KC, CXCL1, Mouse BIO-RAD qMmuCED0003898
Table 2.2 – RT-PCR cycler conditions
Cycles Duration Temperature Step
1 2 min 95◦C Activation
40 15 sec 95◦C Denaturation
45 sec 60◦C Anneling/extension
1 1 min 95◦C
1 1 min 55◦C Melt curve
80 10 sec 55-94.5◦C increase set point temperature after cycle 2 by 0.5◦C
hold 4◦C
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2.14 Lactate dehydrogenase (LDH) assay
The LDH Activity Assay kit (Sigma-Aldrich; #MAK066) was used to assess the presence of dam-
age or toxicity in microglia cells. The assay was performed according to the manufacturer’s
instructions. In brief, samples (microglia supernatants, taken after stimulation) were diluted
1:10 with LDH Assay buffer and the NADH standards were prepared in a 96-well plate with a
volume of 50 µl/sample or standard. Next, 50 µl of the master reaction mix composed of 48 µl
LDH Assay Buffer and 2 µl LDH Substrate Mix, was added on top and the plate incubated at RT
on a horizontal shaker. After 2 minutes, the optical absorbance was measured at 450 nm by an
iMark microplate reader (Bio-Rad) every five minutes until the value of the most active sample
exceeded the value of the highest standard. Finally, the LDH activity was calculated as described
by the manufacturer’s instructions.
2.15 Statistical analysis
Data were presented as mean±SEM and analysed by GraphPad Prism R© 6.01 (Graphpad Soft-
ware). Data sets were analyzed via theMann-Whitney test, multiple t-test or ANOVA and Tukey´s
multiple comparison. Differences of p<0.05 were considered as significant.
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3. Results
3.1 Subpopulation sizes are dependent on the severity of the
challenge
The amount of cytokines like TNFα, released by microglia, correlates well with the severity of
the challenge that they face, while only subsets of microglia are producing this respective cy-
tokine (Regen et al., 2011; Scheffel et al., 2012). However, the principle of organization behind
this phenomenon is still unknown. Here, I investigated the functional link between cytokine re-
lease and subpopulation size as well as a relative cytokine release per cell. Hence, I performed
ELISpot and ELISA experiments for TNFα and RANTES on 1000 microglia cells mixed with in-
creasing concentrations (0.01ng/ml; 0.1 ng/ml; 1 ng/ml, 10 ng/ml, 100 ng/ml and 1000 ng/ml) of
LPS, Pam3CSK4 and MALP-2. The combination of both quantitative techniques allowed a corre-
lation analysis between the cytokine secreting microglia number and the corresponding amount
of secreted cytokines.
Evaluation of the ELISpot experiments for both TNFα and RANTES revealed that the cytokine
secreting subpopulation size and the cytokine secretion increased signifcantly with increasing
stimuli concentrations. At a certain stimuli concentration, the stimuli were not able to induce
a further increase which resulted in a ceilling effect for both measured values (see figure 3.1A,
p.25).
The microglia subpopulations which produced TNFα upon MALP-2 stimulation range from 41.3
% to 77.9 % with a cytokine production of up to 372.6 pg/ml. Stimulation with Pam3CSK4 showed
an increase in the subpopulation size from about 32.5 % to 79.1 %, while the total produced
amount of TNFα rose to a maximum of 688.9 pg/ml. LPS stimulation increased the microglia
subpopulations from 45.1 % to about 87.0 % with a total production of up to 924.7 pg/ml. The in-
creases in the TNFα-producing subpopulations as well as the TNFα production reached a plateau
at concentrations above 0.1 ng/ml for MALP-2 and LPS, and 10 ng/ml for Pam3CSK4 stimulation.
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Figure 3.1 – ELISpot, ELISA and correlation analysis of TNFα and RANTES-producing microglia subpopula-
tions: A) TNFα and RANTES producing subpopulation sizes obtained by ELISpot experiments for microglia
plated at a density of 1000 cells/well. Microglia were stimulated with the indicated concentrations of LPS,
Pam3CSK4 or MALP-2 for 24 hours (bars) and the corresponding amount of the secreted cytokines (lines)
was obtained by ELISA. The stimuli dependent growth is significantly different for all tested conditions
(ANOVA with P < 0.0001 for all subpopulations and TNFα secretions. RANTES secretion has P values of
PMALP−2=0.0002, PPam3CSK4=0.0095 and PLPS < 0.0001). B) Corresponding TNFα and RANTES producing
subpopulation sizes of unstimulated microglia. C) Stimuli-dependent correlation of the cytokine secretion
vs. the associated subpopulation size for TNFα and RANTES analysed with pearson correlation. Data are
presented mean ± SEM. n=8-16
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The microglia subpopulations positive for RANTES showed a similar pattern. MALP-2 stimula-
tion led to an increase from 21.1 % to about 57.6 % with a maximum production of 440.9 pg/ml.
Stimulation with Pam3CSK4 showed an increase from about 17.7 % to 54.8 % and a total cy-
tokine production of up to 480.2 pg/ml. Stimulation with LPS increased the subpopulations from
28.4 % to 67.5 and the RANTES secretion to 2763.2 pg/ml. The plateau reached by the RANTES-
producing subpopulations appeared at similar concentrations observed for the TNFα-producing
subsets, while the cytokine secretion stagnates at concentrations above 0.1 ng/ml forMALP-2 and
10 ng/ml for Pam3CSK4 and LPS stimulation. The obtained results also revealed that a population
of TNFα and RANTES producing microglia is already existing even if the cells were not exposed
to a challenge (see figure 3.1B, p.25). While the subsets comprised 28.1 % of all microglia for
TNFα and 17.3 % for RANTES, measurable cytokine secretion could not be demonstrated in the
unstimulated cells.
Table 3.1 – R2 of cytokine pro-
ducing subpopulation sizes and






The increase in both, subpopulation size and cytokine secre-
tion highly correlates for all tested stimuli regarding TNFα,
with R2 values above 0.9 (see figure 3.1C, p.25) (see table 3.1).
A weaker, though still considerable correlation was found re-
garding RANTES with R2 values of 0.72 for MALP-2, 0.85 for
Pam3CSK4 and 0.74 for LPS stimulation.
To validate the findings from ELISpot, FACS analysis was per-
formed on microglia stimulated with the same concentra-
tions of LPS. Thereby, I was able to confirm the concentra-
tion dependent cytokine producing subpopulation sizes for
both, TNFα and RANTES (see figure 3.2, p.27). The subpopu-
lations for TNFα-secreting microglia increased from 4.6 % at 0.01 ng/ml to 59.5 % while RANTES-
secretion subpopulations increased from 4.7 % to 50.3 %. The significant increase in both, TNFα-
andRANTES-producing subpopulations reached a plateau at LPS concentrations above 0.1 ng/ml.
A second factor besides subpopulation size that contributes to the overall cytokine release is the
cytokine release per cell (see figure 3.3, p.27). TNFα secretion per cell increased significantly
between MALP-2 concentrations of 0.01 ng/ml, 0.1 ng/ml and 1 ng/ml and stagnated at higher
concentrations. LPS-stimulated microglia behaved similarly with significant increases between
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Figure 3.2 – FACS analysis of TNFα and RANTES-producing microglia subpopulations: FACS of microglia
plated at a density of 300000 cells/well and stimulated with LPS for 8 hours was investigated for TNFα and
RANTES producing subpopulation sizes. Subpopulation size progression is significant with P <0.0001 for
TNFα and RANTES (ANOVA). Data are presented as mean ± SEM. n=6
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Figure 3.3 – Amount of cytokine secretion per cell of TNFα- and RANTES-producing microglia subpopula-
tions. Asterisks indicate significant differences between the concentration and the next lower one. Signif-
icance was tested via ANOVA and Tukey’s multiple comparison (ANOVA: P < 0.0001 for all TNFα and the
RANTES LPS group).Data are presented as mean ± SEM. n=8-16)
0.1 and 1 ng/ml and a stabilization afterwards. Pam3CSK4 showed a rather dynamic progres-
sion with a gradual increase of secretion per cell and a peak around 100 ng/ml. No change of
the cytokine secretion per cell could be observed after stimulation with MALP-2 and Pam3CSK4
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regarding RANTES. LPS showed a significant increase from 1 ng/ml to 10 ng/ml and a stable se-
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Figure 3.4 – Analysis of Spot intensity and Spot size of TNFα- and RANTES-producing microglia subpopula-
tions: A) ELISpot intensities of the TNFα and RANTES spots normalized to medium control. B) ELISpot spot
sizes for TNFα and RANTES normalized to medium control; n=6. Significance was tested via ANOVA and
Tukey’s multiple comparison. Asterisks indicate significant differences between the concentration and the
next lower one with a P-value ≤ 0.05. Data are presented as mean ± SEM. n=8-16
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Figure 3.5 – ELISpot analysis of TNFα-producing
microglia populations after combined stimulation:
TNFα and RANTES producing subpopulation sizes ob-
tained by ELISpot experiments formicroglia plated at
a density of 1000 cells/well, stimulated with the in-
dicated concentrations of LPS, Pam3CSK4, MALP-2or
combinations of them for 24 hours; n=8. Asterisks in-
dicate significant differences of LPS and MALP-2 or
Pam3CSK4 combined stimulation to LPS only stimula-
tionwith p-values *≤ 0.05; **≤ 0.005; ***≤ 0.0005 ob-
tained by multiple t-test.Data are presented as mean
± SEM. n=8)
The relationship between subpopulation
size and secretion per cell could be val-
idated by ELISpot as well. An elevation
of the secreted amount could be reflected
by an increase in spot size and/or spot
intensity. Analysis of these factors re-
vealed an increase in the TNFα ELISpot
spot intensity for all stimuli and in the
spot size for MALP-2 and LPS stimula-
tion. The RANTES ELISPOT intensities
as well as spot sizes grew significantly
by MALP-2 and LPS stimulation. No ef-
fect of Pam3CSK4 could be detected con-
sidering RANTES (see figure 3.4, p.28).
The TNFα spot intensity increased signif-
icantly between 0.01 ng/ml, 0.1 ng/ml and
1 ng/ml of MALP-2-stimulated microglia.
Pam3CSK4 led to significant increases be-
tween 0.1 ng/ml, 1 ng/ml and 10 ng/ml and
LPS between medium control and 0.01
ng/ml. RANTES-producing microglia stim-
ulated with MALP-2 and LPS showed no
significant differences in the spot inten-
sity of 0.01 ng/ml compared to medium
only, while Pam3CSK4 could not elicit an increase in the spot intensities.
Analysis regarding ELISpot spot size revealed sparse differences only (see figure 3.4B, p.28).
Significant differences for TNFα were detected for 0.01 ng/ml of MALP-2 and LPS stimulated
microglia compared to medium control. RANTES-producing microglia stimulated with MALP-
2 showed significant differences between 100 ng/ml and 1000 ng/ml while the spot sizes of LPS
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stimulated cells differed between medium and 0.01 ng/ml as well as 1 ng/ml and 10 ng/ml. No dif-
ferences could be observed in Pam3CSK4 stimulated microglia, neither for TNFα nor for RANTES.
Next, a similar experiment with parallel stimuli was performed to investigate whether simulta-
neous stimulation has an additive effect on TNFα producingmicroglia subpopulations. Combina-
tions of LPS and Pam3CSK4, LPS and MALP-2 as well as Pam3CSK4 and MALP-2 at concentration
of 0.01 ng/ml, 0,1 ng/ml and 1 ng/ml were used for this experimental approach. However, no ad-
ditive effect on the subpopulation sizes could be observed (see figure 3.5, p.29). The combination
of LPS with another stimuli in most cases even lead to a slight reduction of the TNFα producing
subpopulation size than a LPS only stimulation. Combination of Pam3CSK4 and MALP-2 showed
no effect at all.
In summary, I could demonstrate a stimuli-dependent increase in TNFα and RANTES-producing
microglia subpopulations via ELISpot and FACS. The subpopulations do not rise infinetly but
reach a plateau at higher stimuli concentrations. The maximal subpopulation sizes could not
be raised any further by a combination of different stimuli. The increase in the subpopulation
sizes correlates highly with an increase in the cytokine secretion, which is more pronounced for
TNFα than RANTES in stimulated microglia. An increase in the cytokine secretion per cell could
also be demonstrated at higher stimuli concentrations, despite this correlation. This increase
was primarily demonstrated in TNFα producing subsets, but also in LPS stimulated RANTES sub-
populations. The increase in the cytokine secretion per cell correlates with an increase in the
intensity of the spots obtained by the ELISpot experiments, which validates this observation
even further.
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3.2 Microglial subpopulation sizes are density dependent
Microglia are heterogeneously distributed throughout the brain, with densities reaching region
dependently from 5 to 12 % (Lawson et al., 1990). To test whether microglia densities affect
the specific subpopulation sizes, I performed ELISpot measurements for TNFα and RANTES in
a similar approach as previously described, though, with higher cell densities (2000 and 3000
cells/well). The high RANTES production exceeded the detection limit, thus a precise spot dis-
crimination was impossible (data not shown). Data from the TNFα ELISpot experiment revealed
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Figure 3.6 – Density dependency of microglia subpopulations analyzed by ELISpot: A) TNFα-producing
microglia subpopulations obtained by ELISpot experiments with microglia densities of 1000, 2000 and 3000
cells/well. Significant differences obtained by ANOVA and Tukey’s multiple comparison with a P-value ≤
0.05 were indicated as followed: * difference between all densities; + differences between 1000 and 2000
cells/well; # differences between 1000 and 3000 cells/well; o differences between 2000 and 3000 cells/well.
B) Correlation between TNFα-producing subpopulation sizes and microglia density analyzed with pearson
correlation. Data are presented as mean ± SEM. n=8
Ulla Gertig 31
3. RESULTS 3.2. MICROGLIAL SUBPOPULATION SIZES ARE DENSITY DEPENDENT
Table 3.2 – R2 of TNFα producing subpopulation sizes vs. microglia density (obtained by pearson correla-
tion)
medium 0.01 ng/ml 0.1 ng/ml 1 ng/ml 10 ng/ml 100 ng/ml 1000 ng/ml
MALP-2 0,774 0,7552 0,6189 0,9188 0,9290 0,9453 0,9536
Pam3CSK4 0,7742 0,8684 0,5917 0,4120 0,6274 0,9270 0,8953
LPS 0,7742 0,9992 0,9963 0,9744 0,9883 0,9973 0,9976
that the TNFα-producing subpopulation sizes are negatively density-dependent as they increase
with decreasing cell density (see figure 3.6, p.31). The previously observed concentration de-
pendent increase in subpopulation size (see figure 3.1, p.25) was observed in densities of 2000
and 3000 cells/well as well, though, saturation was already reached at approximately 60 % and
40 % respectively. Significant differences between the densities could be demonstrated for all
used stimuli. The differences could be either observed between 1000 and 2000 vs. 3000 cells, or
between all densities which became more pronounced with higher stimuli concentrations (see
figure 3.6A, p.31). Correlation analysis of the TNFα-producing microglia subpopulation size and
the plated microglia density demonstrated a negative correlation for most conditions (see figure
3.6B, p.31) (see table 3.2). LPS stimulation resulted in R2 values above 0.97 for all conditions ex-
cept medium (R2 = 0.77). MALP-2 stimulation revealed R2 values of 0.774, 0.7552 and 0.6189 for
medium control and the lower concentrations and R2 values above 0.91 for the higher ones. The
R2 values for Pam3CSK4 were much more heterogeneous reaching from 0.41 up to 0.93.
FACS experiments performed with increasing microglia densities (200000, 300000, 400000 and
500000 cells/well) for TNFα validated these results by showing a similar pattern (see figure 3.7A,
p.33). The higher the density, the lower the secreting subpopulation size which declines at the
highest density to about 82 % of the lowest one. A similar correlation can be observed for
RANTES positive microglia populations, since a significant difference could be demonstrated for
200000 and 300000 cells/well vs. 500000 cells/well; with a decrease to about 75 % of the lowest
density. To rule out a possible effect of increased cell death caused by the relatively high cell
densities, I stained for Zombie, a marker for dead cells. As seen in figure 3.7B, no differences
among the various cell densities could be measured, confirming that none of the used cell densi-
ties biased the observed phenomenon by increased cell death.
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Figure 3.7 – Influence of the cell density on the microglia subpopulation sizes and cell death analyzed by
FACS: FACS analysis of microglia plated at 200000, 300000, 400000 or 500000 cells/well. Microglia were
stimulated with 1 ng/ml LPS for 8 hours and received monensin after 3 hours. Cells were screened for
TNFα, RANTES (A) and Zombie (B) a marker for dead cells. Data was normalized to 200000 cells/well. Data
was analyzed via Mann-Whitney test. Asterisks indicate p-values *≤ 0.05; **≤ 0.005; *** ≤ 0.0005. B) .Data
are presented as mean ± SEM. n=6
As I was able to confirmmy hypothesis on density dependent subpopulation sizes of microglia, it
was now of utmost interest to investigate the principle of organization. Thus, I investigated the
progression of the subpopulation size increase for all densities. The analysis revealed that the
relative increase of the subpopulation size is quite similar regardless of the densities with just
few variations (see figure 3.8A, p.34). For MALP-2-stimulated microglia, significant differences
between cell densities were primarily observed for the medium control and concentrations of
0.01 and 1 ng/ml while all the higher concentrations show no density-dependent differences.
LPS-stimulated microglia show a similar increase, with significant differences for medium con-
trol, 0.1 ng/ml and 1 ng/ml. Pam3CSK4-stimulated microglia showed a more heterogeneous in-
crease and a rather sigmoidal growth curve. Significant differences between the densities were
observed till a concentration of 10 ng/ml.
Furthermore, I wanted to investigate the interplay between subpopulation size and the amount
of secreted TNFα upon a cellular threat. I hypothesized that all secreting microglia secrete the
same amount of TNFα and that microglia regardless of the density reach the same amount of
total TNFα when facing the same threat. By assuming so, a higher microglia density should have
a lower proportion of TNFα-secreting cells than lower microglia densities. However, analysis
of the TNFα-secretion per cell revealed a density dependent secretion as well but in a reversed
pattern (see figure 3.8B, p.34). The results showed that TNFα secretion per cell decreased with
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Figure 3.8 – Density dependent secretion per cell and subpopulation increase: A) Increase of the subpop-
ulation sizes normalized to the highest value obtained for each stimuli and density. B) Denstiy dependent
TNFα secretion per cell. Significant differences obtained via ANOVA and Tukey’s multiple comparison with
P-values ≤ 0.05 were indicated as follows: * difference between all densities; + differences between 1000
and 2000 cells/well; # differences between 1000 and 3000 cells/well; o differences between 2000 and 3000
cells/well. Data are presented as mean ± SEM. n=8
decreasing microglia denstity. This was demonstrated in LPS-stimulated microglia at concentra-
tions above 0.1 ng/ml between all densities. For MALP-2 and Pam3CSK4 stimulations differences
were mostly significant between at least two of the densities with a similar increase in secretion
for microglia plated at 2000 and 3000 cells/well and a lower one for 1000 cells/well.
Alltogether, it was shown that TNFα and RANTES-producing microglia subpopulation sizes de-
pent on the microglia density, as the secreting subpopulation sizes decreased with increasing
microglia denstity. The generell increase of the subpopulation sizes was barely affected by the
density. Additionally, it was shown that microglia of higher densities produce less TNFα per cell
than microglia of low densities. A corruption of the obtained data by increased cell death in
higher densities could be excluded.
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3.3 Microglia subpopulations overlap in their functions
After identification of the TNFα and RANTES producing subpopulations, I investigated their com-
position via FACS analysis. The results show that subpopulations positive for TNFα, RANTES and









































































































































Figure 3.9 – Composition of TNFα- and RANTES-producing microglia subpopulation sizes analyzed via
FACS: Microglia plated at 300000 cells/well were stimulated with medium or LPS (1 ng/ml) for 8 hours.
TNFα- and RANTES-positive cells were analyzed via FACS. A) Representative FACS plots for unstimulated
and stimulated microglia. B) Quantification of the individual subpopulations. C) Quantification of all TNFα-
and RANTES-positive cells. Data was analyzed via multiple t-test (**≤ 0.005; *** ≤ 0.0005). Data are pre-
sented as mean ± SEM. n=6
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Once microglia are stimulated with 1 ng/ml LPS, the cytokine producing microglia population
rises massively. Thereby, I could detect that TNFα-positive microglia are assembled by a popu-
lation that is just positive for TNFα, which increases upon stimulation significantly from 6.4 %
to 38.8 % and a subpopulation that is able to produce TNFα as well as RANTES, which is also in-
creasing significantly upon stimulation from 2.3 % to 25.5 % (see figure 3.9B, p.35). The RANTES-
positive microglia population is also composed of a single and a double producing subpopulation
of microglia. However, for RANTES the single positive microglia population stays more or less
stable upon stimulation (increases insignificantly from 1.5 % to 3.2 %) while the subopopulation
which is able to produce both cytokines increases. The total amount of TNFα- and RANTES-
producing microglia rises after stimulation from about 8.7 % to 64.3 % and 3.7 % to nearly 28.7
%, respectively (see figure 3.9C, p.35).
Thus, I could demonstrate that cytokine producing microglia are composed of microglia that
secrete the investigated cytokine only and those that secrete multiple cytokines at once. The
increase in cytokine release upon LPS stimulation is thereby heterogeneously regulated, as up-
regulation of RANTES is only conveyed by the subpopulation which secreted multiple cytokines
while for TNFα the TNFα specific subpopulation increased as well.
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3.4 Microglia proliferation and cytokine secretion
As I could demonstrate that microglia are able to secrete multiple cytokines as once, I investi-





















































































































































































Figure 3.10 – Proliferation rate of challenged microglia isolated fromWT and transgenic mice. A) Prolifera-
tion rate of WT microglia stimulated with 0.01 ng/ml, 1 ng/ml or 100 ng/ml of LPS or Pam3CSK4 or 25 µg/ml,
50 µg/ml and 100 µg/ml of Fibronectin (FN); n= 14-20. B) Proliferation rate of myd88−/− and triflps2 cells
stimulated with 100 ng/ml of LPS and Pam3CSK4 or 100 µg/ml of FN for 24 hours. n=30-48.The difference
to WT medium levels was analyzed via 2-way ANOVA and Tukey´s multiple comparison with asterisks in-
dicating p-values *≤ 0.05; **≤ 0.005; *** ≤ 0.0005. C) Viability assessment via the WST-1 assay of Microglia
treated with increasing concentrations of BrdU for 24 hours. n=6. Data was analyzed via multiple t-test.
Data are presented as mean ± SEM.
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Since previous studies reported very controversial results on microglia proliferation upon chal-
lenges such as LPS stimulation (Gebicke-Haerter et al., 1989; Chen et al., 2012; Fukushima et al.,
2015; George et al., 2015), I first examined the effect of any challenge on microglia proliferation,
before investigating the temporal orchestration of proliferation and cytokine secretion. There-
fore, I stimulated microglia with increasing concentrations of LPS, Pam3CSK4 (both 0.01 ng/ml; 1
ng/ml; 100 ng/ml), and Fibronectin (FN) (25 µg; 50 µg; 100 µg) for up to 48 hours and performed
subsequently an ELISA based BrdU cell proliferation assay.
Analysis revealed that challenged microglia proliferate significantly less compared to untreated
controls, and that this reduction becomes more pronounced the longer the challenge lasts (see
figure 3.10A, p.37). Microglia stimulated with LPS showed a significant reduction in the prolif-
eration rate for all tested incubation times and concentrations, ranging to a minimum of 22.1%
compared to medium control. The FN-stimulated microglia showed a first impairment of prolif-
eration after 24 hours for all used concentrations. At 48 hours, the decreasing effect seems to be
reversed for low levels of FN (25 µg/ml) but stayed consistent for the other concentrations. Here,
the minimum proliferation rate reached 51.6 % of the medium control. Microglia stimulated
with Pam3CSK4 showed first reductions in the proliferation rate after 12 hours of incubation
with 1 ng/ml and 100 ng/ml. After 24 hours, the proliferation rate was significantly reduced for
all used concentrations with a minimum of 28.6 %.
After demonstrating this reduction in the proliferation rate, I wanted to identify the responsible
signaling pathway. Thus, I performed additional proliferation assays in myd88−/− and triflps2
KO cells. For this purpose, I stimulated WT and KO microglia with high concentrations of the
previously used stimuli for 24 hours (see figure 3.10B, p.37). A comparison between WT and
myd88−/− cells showed that, in contrary to stimulated WT cells, stimulation of myd88−/− cells
with Pam3CSK4 and Fibronectin did not reduce the proliferation rate significantly as it was ob-
served in stimulated WT cells. Only LPS-stimulated KO cells showed a significant reduction com-
pared to unstimulated WT cells. This reduction, however, was much weaker than in LPS-treated
WT cells. In contrast to MyD88-/- cells, triflps2 cells behaved similar to WT cells. The significant
reduction after stimulation was demonstrated for all used stimuli.
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Additionally, I performed anWST-1 viability experiment with increasing concentrations of BrdU
to exclude toxic effects of BrdU, which could bias the obtained proliferation data (see figure
3.10C, p.37). Microglia incubated with increasing concentrations of BrdU for 24 hours showed
no differences in their viability compared to untreated control cells.
After assessment of the general proliferative behavior of challenged microglia, I tested if mi-






























































































































Figure 3.11 – Determination of TNFα-producing and proliferating microglia subpopulation sizes via FACS
analysis: Microglia plated at 300000 cells/well were stimulated with medium or LPS (1 ng/ml) containing 5
µM EdU for 8 hours. TNFα and EdU positive cells were analyzed via FACS. A) Representative FACS plots for
unstimulated and stimulated microglia. B) Quantification of the individual subpopulations. C) Quantifica-
tion of all TNFα and EdU positive cells. Data was analyzed via multiple t-test (*≤ 0.05; *** ≤ 0.0005). Data
are presented as mean ± SEM. n=7-8
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Hence, I performed combined FACS stainings for TNFα and EdU, a marker for proliferating cells.
To do so, I stimulated microglia with 1 ng/ml LPS mixed with 5 µMEdU for 8 hours. The obtained
results of this double staining behaved quite similar to the previously performed one for TNFα
and RANTES (see figure 3.11A, p.39). Unstimulated, TNFα-positive microglia are composed of a
small population of TNFα secreting microglia (10.4 %) and a small population that is positive for
both, secretion and proliferation (6.4 %) (see figure 3.11B, p.39). This composition was also ob-
served for the proliferating microglia subpopulationwhich included a subpopulation of dividing
























Figure 3.12 – Effect of EdU on microglia viability: mi-
croglia were treated with increasing concentrations
of EdU for 24 hours. Viability was assessed via the
WST-1 assay.Data was analyzed via multiple t-test.
Data are presented as mean ± SEM. n=6
LPS stimulation increased the TNFα pro-
ducing subpopulation to 23.95 %, whereas
the double positive microglia population
was stable at a size of 8 %. The proliferat-
ing microglia subpopulation was not sig-
nificantly affected by LPS stimulation but
was slightly reduced to 3.8 %. However,
the total percentage of proliferating mi-
croglia decreased significantly upon LPS
stimulation from approximately 13.1 % to
11.8 % (see figure 3.11C, p.39), which con-
firms my data obtained from the BrdU
proliferation assay. The viability of microglia remained unchanged after a stimulation with in-
creasing concentrations of EdU (see figure 3.12).
In summary, the proliferation rates in LPS, Pam3CSK4 and FN challenged microglia were re-
duced, primariliy driven by the Myd88 signaling pathway. In addition, microglia can multitask
as some cells are able to perform proliferation and cytokine secretion simultaneously. A corrup-
tion of these results by a toxic effect of the used cell division markers could be excluded.
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3.5 Effect of environmental cues on microglia subpopulation
sizes
Knowing that microglia subpopulation sizes are density dependent, the underlying mechanism
conveying this effect is yet to be discovered. As microglia have mostly non-overlapping territo-
ries (Parkhurst andGan, 2010) which excludes a contact-dependent organization, it ismore likely
that the secretion of certain substances could mediate the subpopulation sizes instead. As more
microglia could produce higher amounts of a certain substance this increase in concentration
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Figure 3.13 – Determination of super-
natant effect on TNFα- producing mi-
croglia subpopulation size via FACS anal-
ysis: 200000 Microglia/well were plated
with and without the presence of an in-
sert containing additional 100000, 200000
or 300000 cells/insert and stimulated with
1 ng/ml LPS for 8 hours. The plated 200000
cells were subsequently analyzed for
TNFα. FACS analysis of TNFα-producing
microglia subpopulation size was normal-
ized to values obtained from 200000 cells
without inserts. Data was analyzed via
multiple t-test. Data are presented asmean
± SEM. n=8
To test this hypothesis, I performed an insert ex-
periment by plating 200000 microglia with or with-
out transmembrane inserts containing additional
100000, 200000 or 300000 microglia cells. Stimula-
tion with LPS results thus in supernatants produced
by 200000-500000 cells. Investigation of the plated
200000 cells via FACS showed that the TNFα-positive
microglia proportion was not affected by the super-
natants of increasing microglia densities (see figure
3.13). Since an absent effect could also be caused by
an insufficient mixing of the supernatants, the cy-
tokine production in- and outside of the inserts was
compared as well. Significant differences for the
tested factors were found for RANTES only. Here,
supernatants from inside the inserts with 100000
and 200000 cells contained lower RANTES protein
compared to supernatants from outside (see figure
3.14, p.42).
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Figure 3.14 – Cytokine levels inside and outside of inserts: Supernatant from inside and outside the insert
of the insert experiment were analysed via ELISA to determine the cytokine secretion of IL6, IL12-p40, KC,
MIP1α, MCP-1, RANTES and TNFα. Data was analyzed via ANOVA and Tukey´s multiple comparison with
asterisks indicating p-values *** ≤ 0.0005. Data are presented as mean ± SEM. n=4
To avoid the limitations caused by the insert experiment, an supernatant transfer experiment
with supernatants from different densities with different treatments was performed. The first
experiment revealed no differences in the TNFα-producing subpopulation size between the con-
ditions but a significant difference between the LPS-treated groups (see figure 3.15A, p.43). The
subpopulation sizes were significantly smaller in the groups that received supernatant from the
cells that were already stimulated for 8 hours with LPS compared to the groups that received
LPS after the supernatant transfer. A comparison of the supernatants from 200000 and 500000
cells for each group shows no effect on the subpopulation size.
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To exclude that this decline is caused by a possible exhaustion of the LPS amount in the pre-
stimulated condition, the experiment was repeated with a higher LPS concentration (10 ng/ml)
and subpopulation sizes of TNFα-and RANTES-producing microglia were investigated. These
repetitions were performed together with the master student Robin Hindmarsh. Again, the sub-
population size regarding TNFα did not change between the 200000 cells and the 200000 cells that
received supernatant from 500000 cells, independent of the stimulation paradigm (see figure
3.15B), which also holds true for RANTES (see figure 3.15C). The TNFα-producing subpopulation
sizes of microglia that were stimulated with LPS after the supernatant transfer (approximately
77 %) differed significantly from the sizes of microglia supplemented with already stimulated
supernatant (approximately 55 %). This effect of the pre-stimulation could not be observed for
RANTES.



























































































from 200000 cells 
supernatant 
from 500000 cells 
supernatant 
from 200000 cells  
supernatant 












































































































Figure 3.15 – Supernatant transfer experiment: 200000 or 5000000 microglia cells plated in 12-well plates
were treated as the following: 200000 cells and 200000 cells that received the supernatant of 500000 un-
stimulated cells for 8 hours served as unstimulated controls. 200000 cells and 200000 cells with the super-
natant of 500000 unstimulated cells were stimulated with LPS for 8 hours. 200000 cells were supplemented
for 8 hours with the supernatants of 200000 or 500000 cells that were already stimulated with LPS for 8
hours beforehand. A) Microglia were stimulated with 1 ng/ml LPS and analyzed for the TNFα-producing
subpopulation size. n=2. B) Microglia were stimulated with 10 ng/ml LPS and analyzed for the TNFα-
producing subpopulation and C) the RANTES-producing subpopulation size. n=8. Data was analyzed via
ANOVA and Tukey´s multiple comparison with asterisks indicating significant differences between LPS
stimulated groups with p-values *≤ 0.05; **≤ 0.005; *** ≤ 0.0005. Data are presented as mean ± SEM.
These experiments were partially performed together with the master student Robin Hindmarsh.
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3. RESULTS 3.5. EFFECT OF ENVIRONMENTAL CUES ON MICROGLIA SUBPOPULATION SIZES
In conclusion, it was demonstrated that the supernatant of LPS stimulated microglia can but
doesn´t have to affect the microglia subpopulation sizes, while supernatants of different densi-
ties seems to have no effect.
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3. RESULTS 3.6. TNFΑ EFFECT ON TNFΑ SECRETION
3.6 TNFα effect on TNFα secretion
As the secreted cytokines themselves could affect their own secretion or secretion of other cy-
tokines in a feedback loop, leading to a reduction or increase in production over time I exam-
ined this possible effect as well. To test this, ELISA experiments of microglia pre-stimulated with
TNFα for different durations, ranging from 5 minutes to 24 hours with a subsequent LPS stimu-
lation were perfomed. Pre-stimulated microglia that received medium instead of LPS served as
controls. The analysis of the amounts of secreted cytokines revealed that TNFα pre-incubation
alonewas not able to induce significant cytokine secretion. However, with a successive LPS stim-
ulation, TNFα affected the production of most measured cytokines after a pre-incubation period
of more than 6 hours (see figure 3.16, p.46). The cytokines RANTES, IL12-p40, TNFα and IL6 are
significantly reduced after a pre-incubation period of 6 hours or longer. A significant reduction
for KC emerges at 12 hours. MCP-1 was the only measured cytokine which was unaffected by
the TNFα pre-stimulation. Only a single cytokine showed a significant increase in release after
incubation periods of 6 hours and higher, namelyMIP1α. After observing this effect of TNFα pre-
incubation on cytokine secretion, the experiment was repeated with pre-incubations of RANTES,
MCP-1 and MIP1α. These repetitions were carried out together with the bachelor student Timo
Pauw.
As seen in figure 3.17, pre-incubation with RANTES showed no effect on the cytokine secretion.
While the pre-incubation alone was not able to induce cytokine secretion, the combination with
LPS also had no effect on the amount of secreted cytokines.
Pre-incubationwithMCP-1 showedminor effects on all cytokines except RANTES (see figure 3.18,
p.48). A pre-incubation with MCP-1 alone induced no cytokine production, but the combination
with LPS stimulation induced various changes. IL6, IL12-p40 and KC showed a significant reduc-
tion in their secretion after 24 hours of pre-incubation time. For KC an additional increase was
observed after 3 hours which was absent again at longer incubation periods. TNFα and MIP1α
showed significant increases after 3h and 6 h, respectively. MCP-1 levels showed differences at 10
minutes, 25 minutes and 6 hours and RANTES secretion was not affected by any pre-incubation
period.
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Figure 3.16 – Time dependent effect of TNFα pre-incubation on microglial cytokine and chemokine pro-
duction in general and upon LPS stimulation: Microglia were pre-incubated with 10 ng/ml TNFα for the
indicated time points. After removing TNFα cells were subsequently incubated with fresh medium or stim-
ulated with LPS (1 ng/ml) for 18 hours. Chemokine and Cytokine productionwas assessed using ELISA. Data
was analyzed via Two Way ANOVA and Tukey´s multiple comparison with asterisks indicating significant
differences between LPS stimulated groups with p-values **≤ 0.005; *** ≤ 0.0005. Data are presented as
mean ± SEM. n=16
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Figure 3.17 – Time dependent effect of RANTES pre-incubation on microglial cytokine and chemokine pro-
duction in general and upon LPS stimulation: Microglia were pre-incubated with 0.1 ng/ml RANTES for the
indicated time points. After removing RANTES cells were subsequently incubated with fresh medium or
stimulated with LPS (1 ng/ml) for 18 hours. Chemokine and Cytokine production was assessed using ELISA.
Data was analyzed via Two Way ANOVA. Data are presented as mean ± SEM. n=16. This experiment was
carried out together with the bachelor student Timo Pauw.
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Figure 3.18 – Time dependent effect of MCP-1 pre-incubation on microglial cytokine and chemokine pro-
duction in general and upon LPS stimulation: Microglia were pre-incubated with 0.1 ng/ml MCP-1 for the
indicated time points. After removing MCP-1 cells were subsequently incubated with fresh medium or
stimulated with LPS (1 ng/ml) for 18 hours. Chemokine and Cytokine production was assessed using ELISA.
Data was analyzed via Two Way ANOVA and Tukey´s multiple comparison with asterisks indicating signif-
icant differences between LPS stimulated groups with p-values **≤ 0.005; *** ≤ 0.0005. Data are presented
as mean ± SEM. n=16. This experiment was carried out together with the bachelor student Timo Pauw
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Figure 3.19 – Time dependent effect of MCP-1 pre-incubation on microglial cytokine and chemokine pro-
duction in general and upon LPS stimulation: Microglia were pre-incubated with 100 ng/ml MIP1α for the
indicated time points. After removing MIP1α cells were subsequently incubated with fresh medium or
stimulated with LPS (1 ng/ml) for 18 hours. Chemokine and Cytokine production was assessed using ELISA.
Data was analyzed via Two Way ANOVA and Tukey´s multiple comparison with asterisks indicating signif-
icant differences between LPS stimulated groups with p-values **≤ 0.005; *** ≤ 0.0005. Data are presented
as mean ± SEM. n=16. together with the bachelor student Timo Pauw.
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Figure 3.20 – Effect of TNFα on microglia viability
and RNA levels of cytokines: A) Supernatants from
the TNFα pre-incubation experiments were used to
determine the viability of microglia via the LDH
assay. B) RNA was extracted from microglia pre-
stimulated with 10 ng/ml TNFα for 0 h, 1 h and 12 h
and stimulated with 1 ng/ml LPS for 3 hours. mRNA
levels were measured by RT-PCR, relative mRNA ex-
pression for MCP-1, MIP1α, RANTES, KC and TNFα
was calculated by 2−∆∆CT to medium controls with
Gapdh as the control gene. Data was analyzed via
ANOVA. Data are presented as mean ± SEM. n=4
A pre-incubation with MIP1α in combina-
tion with LPS stimulation affected the se-
cretion of KC, RANTES, TNFα and MIP1α
(see figure 3.19, p.49). While IL6, IL12-p40
and MCP-1 secretions were unaffected,
the secretion of the other cytokines was
elevated. KC levels were increased at 3
hours of pre-incubation time. RANTES
levels increased significantly after 5 min-
utes and stayed relatively stable after-
wards. TNFα showed a significant in-
crease at 5, 15, 20 and 30 minutes as
well as 1.5 and 12 hours of pre-incubation
time. MIP1α pre-incubation enhanced its
own secretion after 1h, 6h and 12 hours of
pre-incubation time. Cells pre-incubated
with MIP1α that received medium instead
of LPS had no significant effect on the
tested cytokines.
Since TNFα was the only tested cytokine
which was able to induce a strong and
consistent effect on the cytokine levels, I
investigated the effect of TNFα in more de-
tail. First, an LDH assay was perfomed to
exclude a toxicity effect of TNFα on the microglial cells due to an excessinve incubation. Upon
tissue damage or toxicity, cells release LDH which leads to an increase in its concentration. No
significant increases between the 0-minute control and the other pre-incubation times for the
LPS stimulated microglia could be detected (see figure 3.20A). Pre-stimulated microglia that re-
ceived medium instead of LPS afterwards also showed no changes in their viability.
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Figure 3.21 – FACS analysis of TNFα pre-incubation effect on TNFα- and RANTES-producing microglia sub-
population sizes: Microglia were pre-stimulated with 10 ng/ml TNFα for 0 h, 1 h, 3 h, 6 h, 12 h and stimulated
with 1ng/ml LPS for 8 hours. Data was normalized to values obtained from 0 h control cells and analyzed
via ANOVA and Tukey´s multiple comparison with asterisks indicating significant differences between LPS
stimulated groups with p-values *≤ 0.05. Data are presented as mean ± SEM. n=8
Next, I investigated if the observed TNFα effect on cytokine secretion is also detectable on the
level of transcription using qPCR. Therefore, microglia were pre-incubated with 10 ng/ml TNFα
for 0, 1 and 12 hours and subsequently stimulated with LPS for 3 hours. The mRNA levels of the
tested cytokines relative to the levels obtained from the negative control revealed no differences
between the three treatment groups of all tested cytokines (see figure 3.20B, p.50). I also wanted
to see if the observed effect of TNFα could affect the cytokine secretion by changing the size of the
producing subpopulation. Thus, I repeated the pre-incubation experiment in a FACS approach
for up to 24 hours of pre-incubation time and 8 h LPS stimulation. The data revealed a reduction
in the TNFα-producing subpopulation size to 77.1 % of the control after a pre-incubation period
of 24 hours (see figure 3.21A). The RANTES-producing subpopulation size was not affected by
the TNFα pre-incubation (see figure 3.21B). Since ELISA and FACS experiments were performed
with different incubation times for LPS (18 and 8 hours, repectively), the observed insignificant
change might be caused by an insufficient incubation time with LPS. Thus, a control ELISA ex-
periment was performed with TNFα pre-stimulated microglia, stimulated with LPS for 8 hours.
As it is shown in figure 3.22, 8 hours of LPS incubation is insufficient to elicit the same effect
that was observed with 18 hours of LPS stimulation on TNFα and RANTES secretion (see figure
3.22, p.52). While IL6, IL12-p40 and MCP-1 showed a reduction in secretion after 12 hours of
pre-incubation time, the levels of KC, MIP1α, RANTES and TNFα were not affected at any pre-
incubation duration.
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Figure 3.22 – Effect of TNFα pre-incubation onmicroglial cytokine and chemokine production after 8 hours
of LPS stimulation: Microglia plated at a density of 15000 cells in a 96-well format were pre-incubated with
10 ng/ml TNFα for 0 h, 1 h and 12 hours and subsequently stimulated with LPS (1 ng/ml) for 8 hours.
Microglia without pre-stimulation that received fresh medium instead of LPS served as medium controls.
Chemokine and Cytokine production was assessed using ELISA. Data was analyzed via ANOVA and Tukey´s
multiple comparisonwith asterisks indicating p-values **≤ 0.005; ***≤ 0.0005. Data are presented asmean
± SEM. n=16
Taken together, only a fraction of cytokines was able to regulate and self-adjust cytokine secre-
tion levels. TNFα had the strongest effect of all tested cytokines even though this effect was
absent on mRNA level. FACS analysis demonstrated an influence of TNFα pre-incubation on the
TNFα-producingmicroglial subpopulations exclusively. A possible cause for the variations in the
effect of the ELISA and FACS experiments could be the incubation time for LPS, as the effect of
TNFα pre-incubation on some cytokines could be only observed after 18 hours but not after 8
hours of LPS stimulation.
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4. Discussion
Microglia are known to be implicated in neurodevelopmental, neuroinflammatory, neurodegen-
erative and neuropsychiatric diseases ((reviewed in Block and Hong, 2005). Immune dysregula-
tion caused by the diseased environment leads to over-activation, exaggerated and/ or inhibited
functions of microglia, which are in most cases associated with neuroinflammation, worsening
the diseases (Maezawa and Jin, 2010; Suzuki K et al., 2013). Treatments aiming to control this
neuroinflammation as therapeutic approaches to oppose the diseases are thus under extensive
investigation. And indeed, antipsychotics, for instance ones used for schizophrenia, are known
to decrease the secretion of several pro-inflammatory factors like TNFα or nitric oxide, suggest-
ing a potentially useful therapeutic effect (Kato et al., 2008, 2007; Kowalski et al., 2003; Sugino
et al., 2009). However, some antipsychotics increase the amount of other pro-inflammatory
cytokines as well (Himmerich et al., 2011; Kluge et al., 2009). This phenomenon and the fact
that microglia also display beneficial, immune-resolving functions, questions the usefulness of
unspecific anti-inflammatory drugs (Biber et al., 2016). Thus, with the emerging awareness of
microglia subpopulations, it would be of utmost importance to identify drugs which specifically
target the aversive microglia while leaving the protective ones unaffected or even supported
(Kamigaki et al., 2016; London et al., 2013). An understanding of microglia subpopulations and
their organization would be the requirement to accomplish the identification of specific drugs.
Though, research addressing this issue is scarcely existing so far. This study investigated the
behavior and organization of different microglia subpopulations to shed some light on this so
far unknown but highly important subject.
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4. DISCUSSION 4.1. MICROGLIA SUBPOPULATION SIZES ARE DYNAMICALLY ADAPTED
4.1 Microglia subpopulation sizes are dynamically adapted in
response to different challenges
Microglia are able to respond to specific stimuli in a dose dependent manner. This was shown
for LPS, Pam3CSK4, staphylococcus aureus, escherichia coli, fibronectin and Lipid A conducted
in in vivo and/or in vitro studies for a broad range of cytokines like TNFα (Janova et al., 2016;
Kielian et al., 2002; Lund et al., 2006; Mildner et al., 2007; Regen et al., 2011). Even though, the
underlying signaling mechanisms are known in most cases, the organizational principle of the
change in the secreted amount was not investigated so far. The lack of investment can be ex-
plained by the former assumption that microglia are a homogenous population of immune cells
(reviewed by Hanisch, 2013). This assumption would allow just one explanation for the change
in the cytokine levels – the secretion per cell has to be altered. However, research from the re-
cent decade strongly suggests a rather heterogeneous character of microglia, offering another
hypothesis which might explain the change in cytokine quantities: Alterations in the relative
portion of secreting cells (Baalman et al., 2015; Butovsky et al., 2006; Chen et al., 2010; Clausen
et al., 2008; Fang et al., 2014; Färber et al., 2005; Gertig and Hanisch, 2014; Kawahara et al., 2009;
Kobayashi et al., 2013; Kocur et al., 2015; Kuhn et al., 2004; Marshall et al., 2014; Noda et al., 2000;
Pannell et al., 2014b; Pepe et al., 2014; Schmid et al., 2002; Shinjo et al., 2014; Trias et al., 2013;
Venkatesan et al., 2010; Wlodarczyk et al., 2015). In the present study, I addressed this question
of how the change in cytokine secretion is organized by investigating TNFα, a cytokine which
was already demonstrated to be produced by a subpopulation of microglia only, and RANTES, a
cytokine that was not investigated regarding subpopulations so far (Scheffel et al., 2012).
By testing the effect of increasing concentrations of LPS, Pam3CSK4 and MALP-2 on TNFα- and
RANTES-producing microglia I was able to demonstrate a variety of important features. Both
TNFα- and RANTES were secreted by microglia subpopulations, which confirms the findings
from Scheffel et al. and adds RANTES production to the list of subpopulational features. As
both randomly chosen cytokines characterize subpopulations of microglia, this characterization
might be a general feature of all cytokines, as it was shown for Interleukin 1 beta as well (Clausen
et al., 2008). Thus, at the first glance, the development of drugs specifically targeting cytokine
producing subpopulations would be feasible.
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In addition, I showed that subpopulation sizes can be modulated in response to a challenge,
for instance by LPS, MALP-2 and Pam3CSK4. In regard to LPS, this phenomenon was already
confirmed in the context of microglial neurotransmitters and neurohormone responsiveness
(Pannell et al., 2014b). There, LPS stimulation lead to an up- or downregulation of the responding
microglia subpopulation sizes.
The effect on subpopulation size, however, experiences a ceiling effect at a certain point of con-
centration, depending on the respective cytokine. This ceiling effect might resemble a physiolog-
ical limitation of the immune reaction in regard to LPS and other immunoreactive substances.
In an intact central nervous immune system, this limitation could prevent an overproduction
of cytokines, which would result in a disruption of homeostasis and finally neurodegeneration.
As dysregulation of microglial cells is considered as part of the pathology in neurodegenerative
diseases, this physiological limitation might be affected as well leading to exacerbated inflam-
matory responses (von Bernhardi et al., 2015).
Furthermore, I have shown that the increase in subpopulation size correlates with cytokine se-
cretion. Hereby, the degree of influence strongly depends on the respective cytokine and might
be limited to certain stimuli. Thus, the increases in cytokine release upon stronger challenges are
caused by an increase in the amount of secreting microglia cells. Though studies in that field of
research are sparse, a single study demonstrated a similar effect in mouse fibroblasts (Tay et al.,
2010). There, single cell analysis of TNFα induced activation revealed that higher doses acti-
vate more cells than lower ones which supports the here demonstrated correlation. The authors
were even able to develop a stochastic mathematical model which reproduces the demonstrated
dynamics quite precisely. As microglia subpopulations behave similarly, it is likely that their
dynamics can be fitted to a model as well, which would be a big step forward in understanding
how this biological system operates.
Though I demonstrated a correlation between microglia subpopulation sizes and cytokine se-
cretion, calculation of the cytokine secretion per cell revealed an increase as well, which seems
to be cytokine- as well as stimuli-dependent. While the TNFα secretion per cell increased with
increasing stimuli concentrations, the RANTES secretion rate altered upon LPS stimulation only.
Interestingly, these findings are in line with macrophage research, showing that the transcrip-
tion factor Gli-3 is expressed by a subpopulation of macrophages only (Ravasi et al., 2002). This
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subpopulation as well as the expression level per cell increased significantly upon LPS stimula-
tion. Even though, these experiments were performed on mRNA and not on protein level, they
endorse the previously described results.
In conclusion, the relationship between the subpopulation size and stimuli strength might be
uniform while the cytokine secretion per cell is cytokine as well as stimuli specific. Thus, a
general conclusion answering the initial question if an increase in the amount of cytokines is
caused by an increase in secreting cells and/ or an increase in secretion per cell cannot be made.
It is possible that there is just an increase in the number of microglia but it is also possible that
there is an additional increase in the amount of secretion per cell. These results highlight the
complex organization behind microglia subpopulations which seems to be stimulus as well as
cytokine dependent. Of course, it cannot be excluded that there are also subpopulations that
vary just in the secreted cytokine amount per cell, but to elucidate this additional research on
other subpopulations is needed. Though, the results imply that microglia subpopulations are
very plastic which would exclude the small possibility that microglia subsets are arising during
a late step in development after tissue invasion. Of course, this origin would make it quite easy
to identify subsets and subset-specific properties which could be targeted by a drug, but reality
seems to be more complicated.
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4.2 Microglia subpopulation sizes and behavior are density
dependent
Different brain regions are known to vary highly in their microglia numbers, which was demon-
strated for mice as well as for humans (Lawson et al., 1990; Mittelbronn et al., 2001). Microglia
numbers differ from 5% to 12 % of all cells in themurine brain and from 0.5 % to 16% in human.
The distinct brain regions are known to display highly diverse characteristics, ranging from mi-
croglial gene expression profiles to receptor abundance (Crain and Watters, 2015; Grabert et al.,
2016). Important factors that play a role in shaping these interregional differences, thereby af-
fecting themicroglia, are the microenvironment and the expression of immunoregulatorymark-
ers (de Haas et al., 2008; Ren et al., 1999; Schmid et al., 2009; Smith et al., 2013; Wu et al., 1997).
Whether the density of microglia by itself contributes to this variation is yet unknown. Though
there is evidence for a density dependent effect of microglia, as differences in their abundance
affect LPS-induced neurotoxicity of neurons in vitro (Kim et al., 2000).
Thus, I hypothesized that microglia densities play a role in shaping microglia subpopulations
as well. By investigating the TNFα- and RANTES- producing microglia subpopulation sizes in
microglia of increasing densities, I demonstrated a negative correlation between subpopulation
size and density upon LPS, MALP-2 or Pam3CSK4 stimulation.
I assumed that this dampening in microglia subpopulation size increase might be caused by
a self-regulatory mechanism, preventing the microglia from TNFα overproduction. However,
analysis revealed a positive correlation between density and secretion per cell as well. It can
thus be concluded that denser microglia have a smaller proportion of TNFα producing cells,
though, with a significantly higher relative TNFα production. As a result, denser microglia popu-
lations produce significantly more TNFα than populations of lower density when facing an equal
threat. The potential inflammatory consequences of this phenomenon are intense as a shift in
cell density by a factor of 3 might result in a fourfold higher cytokine concentration.
The relationship between microglia abundance and cytokine secretion, which likely applies for
cytokines in general, has therefore a very strong impact on the force of the immune reaction,
which appears to be more aggressive in higher densities. As microglia densities vary within
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brain regions, it could be hypothesized that the different susceptibilities to an immune challenge
between the regions are caused by this density dependent intensity of the immune reaction.
This hypothesis would fit to an observation made by Kim at al. (2000) as they described an in-
creased LPS-induced neurotoxicity for increasing microglia:neuron ratios. An overproduction
of cytokines is at certain concentrations toxic to neurons. The correlation between the microglia
abundance and the increase in TNFα secretion might be a reasonable explanation. This hypoth-
esis is supported by the fact, that microglia expand their number during chronic neurodegener-
ative disease progression, which is linked to an increased neuronal degeneration (Gómez-Nicola
et al., 2013).
Interestingly, the described density dependence had no effect on the relative increase of the sub-
population size, which was similar between all tested densities. This observation would fit to a
hypothesis made by Ravasi and Hume, who claimed that macrophage heterogeneity arises from
transcriptional probability (Ravasi et al., 2002). Each gene would thus have a specific activation
probability which rises upon challenges like LPS stimulation. Assuming that this hypothesis ap-
plies for microglia as well the uniform increase in subpopulation sizes regarding different cell
densities might be caused by a static expression probability of the TNFα gene, regardless of the
relative cell abundance.
It can thus be concluded that the microglia density has a huge effect on shaping microglia sub-
populations in size and effect intensity, though not on the stimuli induced progression, which
instead might be organized in a probabilistic manner. The blockage of microglia expansion
could serve as a useful therapeutic approach, by limiting the microglia density, thereby delay-
ing disease progression. Indeed, pharmacological treatment which inhibits microglial prolifer-
ation was just recently shown to prevent the progression of Alzheimer´s-like pathology in mice
(Olmos-Alonso et al., 2016).
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4.3 Microglia subpopulations are highly complex organized
Microglia perform a whole set of different functions. Recent research could demonstrate that
they are organized in functional subpopulations to achieve this diversity (Marshall et al., 2014;
Venkatesan et al., 2010). As demonstrated here and elsewhere, secretion of cytokines is per-
formed by microglia subsets as well (Scheffel et al., 2012). However, how the secretion of mul-
tiple cytokines is organized is largely unknown. Only a single study gave evidence that TNFα
and interleukin 1 beta are produced by largely non-overlapping microglia subpopulations after
ischemic stroke inmice (Clausen et al., 2008). However, no further research addressing this topic
has been conducted ever since. Thus and to gain further insight into that topic, I investigated the
organization of TNFα and RANTES secreting subpopulations. Since both substances can be se-
creted bymore than half of the microglia population, I hypothesized that specific subpopulations
are likely to overlap. Analysis of unstimulated and LPS stimulated microglia subpopulations
showed that, indeed, a microglia subset producing both TNFα and RANTES simultaneously ex-
ists. Cytokine-specific microglia were present as well, though behaved rather heterogeneous in
response to a challenge, indicating an organization of those cells in even further subsets. While
the proportion of TNFα positive and double positive microglia rose significantly upon stimula-
tion, the RANTES positive population remained stable. Thus, it appears that there exists a more
general microglia population, able to produce multiple cytokines and to adapt their size in re-
sponse to challenges. In addition, there are more specialized subpopulations producing one
cytokine only. Those subpopulations can, depending on the cytokine they produce, also adapt
their size.
This complex organization of microglia subpopulations was also demonstrated by other studies
in regard to receptor expression. Investigation of microglial CXCR4 and CXCR7 receptors re-
vealed a subpopulation of 55 % which co-expressed those receptors and subpopulations of 20
% and 6 % expressing only CXCR4 or CXCR7 respectively (Lipfert et al., 2013). Consecutive ap-
plication of galanin, somatostation and angiotensin II to neonatal mouse microglia resulted in
microglia subsets of 31 % responding to one stimulus, 8 % to two stimuli and 2 % that responded
to all stimuli (Pannell et al., 2014b). They could also demonstrate a large number of microglia
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subpopulations expressing different subsets of neurotransmitter receptors leading to a huge di-
versity in their sensitivity.
In summary, cytokine secreting microglia subpopulations are composed of different subpopu-
lations producing different cytokines or combinations, leading to heterogeneity within hetero-
geneity, finally resulting into an almost infinite organization complexity. My data support the
possibility for transcriptional probability dependent heterogeneity. If LPS increases the possibil-
ity of certain genes to be expressed in each cell, a random landscape of microglia heterogeneity
would emerge with each cell expressing different sets of genes. Giving our current knowledge
onmicroglia heterogeneity, this complexity, however, makes a targeted drug development rather
difficult, as specific cytokines are not exclusively produced by specific subsets but a combination
of them. Investigating heterogeneity in microglia even further, identifying the whole variety
within the “microgliome” is thus of utmost importance for future research.
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4. DISCUSSION 4.4. MICROGLIA ARE MULTITASKING CAPABLE
4.4 Microglia are multitasking capable as they perform cy-
tokine secretion and proliferation simultaneously
So far, the capability of microglia to perform various different functions was termed multitask-
ing (Casano and Peri, 2015). Multitasking, however, would indicate that microglia are able to
perform several functions simultaneously, a feature which was not demonstrated for microglia
so far, as most of the investigations were performed via bulk measurement. Investigation of mi-
croglia on single-cell level would be necessary to validate or disprove their multitasking abilities.
Thus, I decided to investigate this issue by addressing proliferating microglia. As proliferation
is one of the cells’ most important and thus tightly controlled functions, it would be of great
interest to know whether dividing microglia perform other tasks besides proliferation itself si-
multaneously. Therefore, I examined whether microglia are able to perform proliferation and
TNFα secretion upon a challenge with LPS at once.
The effect of LPS on microglia proliferation is controversially issued in the literature. Microglia
proliferation was shown to be either unaffected, increased, decreased or even both upon LPS
stimulation, depending on the brain region (Chen et al., 2012; Fukushima et al., 2015; Gebicke-
Haerter et al., 1989; George et al., 2015).
To gain further insight on this debate, I investigated the effect of LPS on microglia proliferation
beforehand. The obtained results showed a reduction in the proliferation rate of microglia upon
LPS stimulation, which confirms the findings of Gebicke-Haerter et al. (1989). This reduction,
which was observed for immune challenges with Pam3CSK4 and fibronectin as well, might be
initiated to prevent an excessive immune response caused by higher microglia densities. As
microglia proliferation increases in chronic neurodegenerative diseases, this preventive mecha-
nism is likely to become disrupted in those disorders.
Next, I investigated un- and LPS stimulated microglia for TNFα-secreting and proliferating sub-
populations. Analysis revealed that microglia are able to perform both tasks simultaneously.
Again, subpopulations positive for just one of the investigated functions were discovered as
well. LPS stimulation lead, as expected, to an increase of the TNFα producing subpopulation.
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The subpopulations positive for both functions or proliferation only were not affected signifi-
cantly. However, the previously observed reduction in microglia proliferation upon stimulation
was confirmed in this approach as well.
Thus, it can be concluded that microglia are indeed capable of multitasking as some cells can
proliferate and secrete cytokines at once. This capability might be a general feature, allowing the
conduction of all possible functions simultaneously with at least a second one. This organization
again supports the hypothesis that heterogeneity arises from transcriptional probability.
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4.5 Microglia subpopulation size is influenced by environ-
mental cues
As microglia subpopulation sizes are dependent on the microglia density, the question arises
how this effect is mediated. Since microglia have mostly non-overlapping territories a contact-
dependent organization is doubtful, leaving a substance-dependent organization as a possible
alternative (Parkhurst and Gan, 2010). Since microglia functions are demonstrated to be influ-
enced by the microenvironment, this explanation would be quite likely (Schmid et al., 2009; Wu
et al., 1997).
Therefore, I hypothesized that microglia subpopulations are organized by one or more sub-
stances that are secreted by denser microglia in a heterogeneous manner. To proof this, I per-
formed an insert experiment exposing microglia to supernatants from different microglia den-
sities upon LPS stimulation. Unfortunately though, this method was not able to demonstrate
any effect on the TNFα-producing microglia subpopulation size. Further research demonstrated
that not all substances can pass through the insert membrane unhindered. Therefore, a more
adequate experimental approach was needed for testing a supernatant induced effect.
To mimic a more accurate microenvironment, I thus performed a supernatant transfer exper-
iment. Microglia, which were incubated with supernatants of increasing microglia densities,
showed no density dependent differences in the TNFα- and RANTES-producing microglia sub-
population sizes. LPS stimulation which followed this supernatant transfer showed a similar
outcome. These results indicate that the supernatant of unstimulated microglia has no effect,
independent of the microglia density, suggesting a similar composition of the substances within
the supernatants.
Microglia supplemented with supernatants of LPS stimulated microglia of increasing densities
showed a reduced proportion of TNFα producing cells compared to microglia that were directly
LPS stimulated. Thereby, the subpopulation sizes were independent from the density, presum-
ably as the concentrations of signaling molecules already reached saturation. This effect was ab-
sent in RANTES-producingmicroglia, indicating a cytokine-specific regulation of subpopulations.
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This regulation is likely caused by an immune challenge and is not necessarily defined before-
hand. However, further studies investigating a time course of regulatory signals are necessary
to unravel a differential effect by microenvironment compositions and to clarify the underlying
mechanisms.
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4.6 Organization of microglia subpopulation sizes is partially
self-regulated
The demonstrated impact of the microenvironment on microglial subpopulations gave rise to
new questions on the exact factors modulating this effect. Signaling of certain cytokines like
IL6 leads to the suppression of its own production and/ or the production of other cytokines
(Greenhalgh and Hilton, 2001). I hypothesized that cytokine signaling not only encompasses this
negative feedback loop but also has an effect on the cytokine secreting subpopulation sizes.
To investigate this possibility, I examined the effect of TNFα on its own secretion and the secre-
tion of other cytokines, namely IL6, IL12-p40, KC, RANTES, MIP1α and MCP-1 induced by LPS
exposure.
The analysis revealed a striking difference between cytokine levels of LPS stimulated microglia
and LPS stimulated microglia that were pre-stimulated with TNFα for more than 6 hours. The
pre-incubation caused a marked reduction in IL6-, IL12-p40-, KC-, RANTES- and TNFα secretion,
while the secretion of MIP1α was upregulated and the secretion of MCP-1 unaffected. As higher
doses of TNFα were shown to induce increased productions of TNFα and IL6, suggesting a posi-
tive feedback loop, these results are quite contradicting (Kuno et al., 2005). One possible expla-
nation might be the difference in initial TNFα concentrations and LPS stimulation, highlighting
a dynamic self-regulation by TNFα rather than an unidirectional feedback loop.
Similar experiments using different cytokines were not able to induce a similar significant out-
come. While RANTES had no effect at all, MCP-1 had just minor, non-stable effects on some
cytokines. MIP1α elicited an increased release of RANTES, TNFα and its own, though, the differ-
ences were marginal compared to the previously described TNFα pre-incubation.
This outcome indicates that some cytokines like TNFα have a special status as they are able
to effectively regulate the secretion of other cytokines. Correspondingly, microglia activation
upon LPS is partially mediated by the microglia-derived TNFα and in liver cells, TNFα regulates
chemokine induction after infection with mycobacterium tuberculosis (Kuno et al., 2005; Roach
et al., 2002). No evidence is given by the literature for regulatory effects of RANTES, MCP-1 or
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MIP1α on cytokine secretion, underlining the special status of TNFα.
Based on these results, TNFα seemed to be the most promising cytokine that could affect the
cytokine secreting subpopulation size. Even though, the differences elicited by TNFα pre-
incubation on the cytokine release could not be observed on mRNA level, a slight reduction
in the TNFα producing subpopulation size was present at a pre-incubation time of 24 hours.
The RANTES-producing subpopulation size was not affected by the pre-incubation. The quan-
titative difference between the secreted cytokines and subpopulation size regarding TNFα pre-
incubation might be a consequence from a differential duration of LPS stimulation.
Nevertheless, a small effect of TNFα on the TNFα-producing microglia subpopulation size was
demonstrated, indicating a self-regulating property of TNFα. This regulatory effect can likely be
expanded to other cytokines as well as it is indicated by the ELISA data. To confirm this, further
research is needed.
This self-regulation might explain the density caused differences in the TNFα-producing mi-
croglia subpopulation sizes. As microglia of a higher density produce much more TNFα than
microglia of a lower density, the secreted TNFα could have a stronger effect on the microglia
subpopulation size leading to a more pronounced reduction. Conclusively, the increased secre-
tion would lead to a smaller subpopulation size in denser microglia than in less dense microglia
which would fit to the observed density effect.
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In this study, I investigated the functional heterogeneity of microglia using cytokine secretion
as a hallmark for an immune response. I was able to show that not all microglia but mere
subpopulations secrete cytokines upon an immune challenge. Thereby, increasing severity of
the challenge correlated with the subpopulation size and the amount of the secreted cytokines.
The immune response was strongly cytokine and stimuli dependent, indicating an enormous
plasticity of the subsets. This plasticity was not only demonstrated regarding the population
size but also the cytokine secretion per cell, which was cytokine specifically regulated as well.
Furthermore, I identified the microglial density as an additional factor shaping microglia sub-
populations in size and efficiency. An increase in microglia density lead to a lower proportion
of subpopulations and simultaneously to a higher cytokine production per cell, which finally re-
sults in amuch stronger immune response. Interestingly, cell density has no effect on the stimuli
induced progression of the subpopulation size increase, which instead might be organized in a
probabilistic manner. The general effect of microglia density on the subpopulation size is likely
caused by an immune challenge and not necessarily defined beforehand. This effect is most
probably conveyed via secreted substances, as I could identify TNFα as one of them. TNFα has
a regulatory effect on its own secretion and the secretion of other cytokines, which affects the
cytokine producing subpopulation size as well. As TNFα in most cases leads to a reduction of the
cytokine secretion, it might be considered as a mechanism to resolve the immune response.
Additionally, I was able to demonstrate the complex organization of subpopulations and their
ability to perform multitasking. Thus, microglia subsets perform a variety of functions that
might partially be shared by different subpopulations. This organization was identified for sim-
ilar functions like secretion of different cytokines but also for different functions like cytokine
secretion and proliferation.
Altogether, I could demonstrate that microglia can be categorized in functional subpopulations,
which can be adapted as a response to a challenge. This adaptation might be highly specific as
it depends on function, stimuli and microenvironment. Additionally, function specific subpopu-
lations are composed of even more specific “subsubpopulations”, which provides a small insight
Ulla Gertig 67
5. SUMMARY AND CONCLUSION
into the high complexity and the infinite possibilities of microglia subsets. Further investiga-
tion of microglia heterogeneity to identify the whole variety within the “microgliome” is thus of
utmost importance for future research.
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